Data / Research funding / Biotechnology
Biotechnology: 23,386 NIH awards ($32B) and 1,643 NSF awards ($1.7B) to 2,362 organizations
23,386 NIH awards ($32B) and 1,643 NSF awards ($1.7B) in the NIH spending category Biotechnology and the NSF reference name Biotechnology, to 2,362 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category and NSF reference name
Awards
The 500 largest of 25,029 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $417,904,831 | August 15, 2023 | August 14, 2024 | STROKES, BAMBRA | reporter.nih.gov |
| HIV Vaccines Clinical Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $244,071,463 | June 29, 2006 | November 30, 2027 | COREY, LAWRENCE | reporter.nih.gov |
| HIV Vaccine Trials Network Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $177,480,054 | June 29, 2006 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| National High Magnetic Field Laboratory Renewal 2023-2027 | NSF | Materials Research Section | 2023 | $156,947,247 | January 1, 2023 | December 31, 2027 | Kathleen M Amm | nsf.gov |
| SDMC: HIV Vaccine Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $156,744,802 | June 29, 2006 | November 30, 2027 | GILBERT, PETER B. | reporter.nih.gov |
| CoVPN LOC Cross-Protocol Infrastructure Supplement for GY15 and GY16 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $156,469,927 | March 30, 2022 | March 31, 2022 | COREY, LAWRENCE | reporter.nih.gov |
| Consortium for HIV/AIDS Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $145,502,241 | July 1, 2019 | June 30, 2026 | BURTON, DENNIS R. | reporter.nih.gov |
| Induction of protective antibodies for HIV vaccine development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $143,048,158 | July 15, 2019 | June 30, 2026 | HAYNES, BARTON F. | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $72,825,966 | September 10, 2019 | September 24, 2026 | KRAMMER, FLORIAN | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $69,157,920 | January 20, 1997 | March 31, 2026 | VICKERS, SELWYN M | reporter.nih.gov |
| NCI Early Career Cancer Clinical Investigator Award | NIH | National Cancer Institute | 2021 to 2025 | $65,560,307 | March 10, 1997 | November 30, 2026 | EBERT, BENJAMIN LEVINE | reporter.nih.gov |
| Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $63,155,364 | December 5, 2019 | November 30, 2026 | STEPHENS, DAVID S | reporter.nih.gov |
| The Long Life Family Study | NIH | National Institute on Aging | 2021 to 2025 | $60,108,132 | August 15, 2019 | June 30, 2030 | PROVINCE, MICHAEL A. | reporter.nih.gov |
| CoVPN 5001 - A prospective study of acute immune responses to SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $57,987,348 | March 21, 2022 | March 31, 2022 | GILBERT, PETER B. | reporter.nih.gov |
| HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals: LC 3 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $54,331,950 | March 18, 2022 | March 31, 2022 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $53,879,677 | September 10, 2019 | September 9, 2026 | ROSS, TED | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $52,452,735 | September 10, 2019 | September 9, 2026 | MOODY, TONY | reporter.nih.gov |
| Broad-Color: The Genome Center for the Future of All of Us | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $49,829,279 | August 1, 2024 | July 31, 2026 | GABRIEL, STACEY | reporter.nih.gov |
| Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,959,734 | August 13, 2025 | November 30, 2026 | KOTLOFF, KAREN L. | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,296,051 | August 26, 2019 | March 13, 2028 | DENNY, THOMAS | reporter.nih.gov |
| Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT) | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $39,483,481 | September 18, 2018 | July 31, 2028 | LAM, WILBUR A | reporter.nih.gov |
| Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders | NIH | National Institute of Mental Health | 2021 to 2024 | $39,202,732 | July 1, 2003 | February 28, 2026 | KNOWLES, JAMES A | reporter.nih.gov |
| Human Pancreas Analysis Program for Type 1 Diabetes - HPAP-T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $37,867,556 | September 20, 2016 | June 30, 2029 | NAJI, ALI | reporter.nih.gov |
| University of Michigan Rogel Cancer Center Support Grant 2023-2028 | NIH | National Cancer Institute | 2021 to 2025 | $36,682,234 | June 1, 1997 | May 31, 2028 | FEARON, ERIC R. | reporter.nih.gov |
| Vanderbilt Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $36,564,580 | December 11, 2019 | November 30, 2026 | CREECH, CLARENCE BUDDY | reporter.nih.gov |
| Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $36,418,175 | September 15, 2017 | August 31, 2031 | HAMADANI, MEHDI HUSSAIN | reporter.nih.gov |
| Recruitment and Retention for Alzheimer's Disease Diversity Genetic Cohorts in the ADSP (READD-ADSP) | NIH | National Institute on Aging | 2022 to 2025 | $35,910,792 | July 1, 2022 | June 30, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| CLINICAL TRIALS MONITORING SERVICE_ Moonshot support | NIH | National Cancer Institute | 2022 to 2025 | $34,785,582 | May 1, 2022 | April 30, 2026 | ANDERSON, BARRY | reporter.nih.gov |
| Production of Aluminum Based Adjuvants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,078,534 | September 20, 2017 | December 31, 2026 | MACK, FRED | reporter.nih.gov |
| Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $33,014,143 | September 25, 2023 | April 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $32,609,322 | August 2, 2001 | June 30, 2027 | EBERLEIN, TIMOTHY J. | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $31,474,131 | September 26, 2025 | September 25, 2026 | reporter.nih.gov | |
| Mid-scale: Operations of the Center for High Energy X-ray Science (CHEXS) | NSF | Materials Research Section | 2024 | $31,000,000 | September 1, 2024 | March 31, 2029 | Joel D Brock | nsf.gov |
| A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research | NIH | National Cancer Institute | 2021 to 2025 | $30,268,190 | March 1, 1998 | February 29, 2028 | SHAW, BRONWEN | reporter.nih.gov |
| DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $30,010,720 | May 2, 2019 | April 30, 2027 | WEBBY, RICHARD JOHN | reporter.nih.gov |
| Task V15: Development of Assays and Reagents for mpox Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $28,751,383 | September 1, 2022 | April 30, 2026 | RUDGE, THOMAS | reporter.nih.gov |
| Northwest Genomics Center for All of Us | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $28,703,333 | September 25, 2018 | July 31, 2024 | JARVIK, GAIL PAIRITZ | reporter.nih.gov |
| RADX-TECH - LUMINOSTICS, INC. SMARTPHONE-BASED TEST FOR RAPID SARS-COV-2 ANTIGEN DETECTION FROM NASAL SWABS | NIH | National Heart, Lung, and Blood Institute | 2021 | $28,624,460 | September 30, 2020 | September 29, 2021 | RAJA, BALA | reporter.nih.gov |
| Generation, Characterization, and Validation of Marmoset Models of Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $28,395,368 | September 1, 2022 | August 31, 2027 | SILVA, AFONSO C | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $27,888,290 | September 23, 2025 | September 22, 2026 | OSBORNE, C KENT | reporter.nih.gov |
| REACH: Research Enterprise to Advance a Cure for HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,533,114 | August 16, 2021 | April 30, 2027 | JONES, R. BRAD | reporter.nih.gov |
| NIAID Centers of Excellence for Influenza Research and Response (CEIRR): Avian Influenza Research Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,250,171 | April 1, 2021 | January 14, 2027 | LOWEN, ANICE | reporter.nih.gov |
| Alliance Central: A platform for sustainable development of next generation genome knowledgebases | NIH | National Human Genome Research Institute | 2021 to 2025 | $26,776,044 | September 18, 2019 | June 30, 2029 | STERNBERG, PAUL WARREN | reporter.nih.gov |
| A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $26,526,303 | September 20, 2023 | July 31, 2027 | JIANG, YONG-HUI | reporter.nih.gov |
| B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $26,314,793 | June 1, 2022 | May 31, 2027 | HUNTER, ERIC | reporter.nih.gov |
| Collaboratory of AIDS Researchers for Eradication (CARE) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $26,234,170 | August 16, 2021 | April 30, 2027 | MARGOLIS, DAVID M. | reporter.nih.gov |
| Baylor College of Medicine/Stanford University Clinical Genome Resource (CLINGEN) | NIH | National Human Genome Research Institute | 2021 to 2025 | $26,073,883 | September 12, 2017 | June 30, 2027 | PLON, SHARON E. | reporter.nih.gov |
| Center for Dental, Oral, and Craniofacial Tissue and Organ Regeneration (C-DOCTOR) | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $25,635,194 | May 7, 2020 | April 30, 2026 | CHAI, YANG | reporter.nih.gov |
| EO14042 DEVELOPMENT, STATISTICAL DESIGN, MONITORING AND COORDINATION OF VISION CLINICAL TRIALS AND EPIDEMIOLOGY RESEARCH | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $25,277,032 | November 1, 2021 | October 31, 2026 | MENEZES, SUPRIYA | reporter.nih.gov |
| ECHO Laboratory Core at Vanderbilt for Integrated Sample Biobanking and Processing | NIH | Office of the Director, National Institutes of Health | 2023 to 2025 | $24,899,976 | September 1, 2023 | May 31, 2030 | HALASA, NATASHA BASSAM | reporter.nih.gov |
| ASPirin in Reducing Events in the Elderly - eXTension | NIH | National Institute on Aging | 2021 to 2023 | $24,851,437 | July 15, 2019 | April 30, 2026 | MURRAY, ANNE M | reporter.nih.gov |
| The Clinical Genome Resource – Advancing genomic medicine through biocuration and expert assessment of genes and variants at scale | NIH | National Human Genome Research Institute | 2021 to 2025 | $24,744,938 | September 12, 2017 | June 30, 2027 | BERG, JONATHAN S | reporter.nih.gov |
| BIOLOGICAL TESTING FACILITY-REGULATORY, DATA ANALYSIS, DATABASE, AND PROJECT MANAGEMENT | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $24,519,991 | July 2, 2025 | July 1, 2027 | BURNIN, DEBRA | reporter.nih.gov |
| ABCD-USA Consortium: Coordinating Center | NIH | National Institute on Drug Abuse | 2021 to 2025 | $24,150,007 | September 30, 2015 | March 31, 2027 | JERNIGAN, TERRY L. | reporter.nih.gov |
| TO PROVIDE SEQUENCING SERVICES USING WHOLE GENOME SEQUENCING (GERMLINE FFPE) FOR NCI (KLEIN) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $24,069,896 | September 27, 2023 | December 31, 2025 | DOHENY, KIM | reporter.nih.gov |
| CRISPR for Cure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,038,480 | August 16, 2021 | April 30, 2027 | KHALILI, KAMEL | reporter.nih.gov |
| SDMC: HIV Prevention Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $23,565,144 | June 29, 2006 | March 31, 2022 | DONNELL, DEBORAH J | reporter.nih.gov |
| I4C 2.0: Immunotherapy for Cure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $23,329,181 | August 16, 2021 | April 30, 2027 | BAROUCH, DAN H. | reporter.nih.gov |
| Science and Technology Center for Quantitative Cell Biology | NSF | Infrastructure, Institutes, & Centers | 2023 | $23,259,388 | September 15, 2023 | August 31, 2028 | Zaida A Luthey-Schulten | nsf.gov |
| Vaccine and Treatment Evaluation Units | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $22,981,366 | December 11, 2019 | November 30, 2026 | ROUPHAEL, NADINE GEORGES | reporter.nih.gov |
| MANUFACTURE OF CLINICAL GRADE EPSTEIN-BARR VIRUS VACCINE | NIH | National Cancer Institute | 2023 to 2025 | $22,579,077 | September 22, 2025 | September 21, 2027 | reporter.nih.gov | |
| SOSIP-NP/mRNA combination for novel preventive and therapeutic HIV-1 vaccine regimens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $21,986,953 | September 2, 2022 | June 30, 2027 | WILLIAMS, WILTON B | reporter.nih.gov |
| Idaho INBRE Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,939,274 | September 30, 2001 | August 31, 2030 | BOHACH, CAROLYN HOVDE | reporter.nih.gov |
| Broad-Geisinger Clinical Genome Resource | NIH | National Human Genome Research Institute | 2021 to 2025 | $21,876,044 | September 23, 2013 | June 30, 2027 | REHM, HEIDI L | reporter.nih.gov |
| UCCC P30 Supplement: Human Endogenous Retrovirus-H as a Target for Early-Onset Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $21,851,455 | September 1, 2025 | August 31, 2026 | SCHULICK, RICHARD D | reporter.nih.gov |
| UZ-UCSF CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,624,239 | September 9, 2025 | November 30, 2027 | CHIRENJE, ZVAVAHERA MIKE | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,571,641 | August 1, 1997 | November 30, 2027 | CARPTEN, JOHN D. | reporter.nih.gov |
| Boston HIV CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,445,869 | January 15, 2007 | November 30, 2027 | KURITZKES, DANIEL R. | reporter.nih.gov |
| Partnerships for Biomedical Research in Arkansas | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,309,096 | September 30, 2001 | April 30, 2026 | CORNETT, LAWRENCE E | reporter.nih.gov |
| Vaccine and Treatment Evaluation Unit at Saint Louis University | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,219,564 | December 11, 2019 | November 30, 2026 | HOFT, DANIEL F. | reporter.nih.gov |
| NICEATM Support Contract: Optional Level of Effort | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $21,104,694 | May 5, 2015 | November 4, 2025 | ALLEN, DAVID | reporter.nih.gov |
| SCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP) | NIH | National Institute on Drug Abuse | 2022 to 2025 | $20,858,598 | March 23, 2022 | December 31, 2025 | WILCOX, KAREN | reporter.nih.gov |
| Nebraska Research Network in Functional Genomics | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,833,603 | September 30, 2001 | April 30, 2026 | SORGEN, PAUL L | reporter.nih.gov |
| New Mexico IDeA Networks of Biomedical Research Excellence (INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,744,885 | September 30, 2001 | March 31, 2029 | LUSETTI, SHELLEY | reporter.nih.gov |
| Frontotemporal Dementia: Genes, Images, and Emotions | NIH | National Institute on Aging | 2021 to 2025 | $20,694,825 | September 1, 2002 | April 30, 2028 | GORNO TEMPINI, MARIA LUISA | reporter.nih.gov |
| ADDING ADDITIONAL FUNDS UNDER OPTION PERIOD 1, TASK AREAS 5 AND 6, FOR CORE YEAR 5. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $20,653,069 | September 28, 2020 | September 27, 2023 | BOLTON, ASHLIN | reporter.nih.gov |
| COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $20,632,183 | September 30, 2023 | September 29, 2024 | DENNY, THOMAS | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial Program | NIH | National Institute on Aging | 2024 to 2025 | $20,406,409 | September 1, 2024 | August 31, 2029 | ALEXANDER, ROBERT C | reporter.nih.gov |
| West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,261,619 | September 30, 2001 | July 31, 2029 | JOSHI, TRUPTI | reporter.nih.gov |
| Center for Integrated Cellular Analysis | NIH | National Human Genome Research Institute | 2021 to 2025 | $20,096,749 | June 1, 2020 | August 31, 2029 | SATIJA, RAHUL | reporter.nih.gov |
| Reversing Immune Dysfunction for HIV-1 Eradication | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $20,001,273 | August 16, 2021 | October 31, 2026 | CHANDA, SUMIT K | reporter.nih.gov |
| Research Infrastructure: Mid-scale RI-1 (M1:IP): LaNeXT - The Laboratory for Next Generation X-ray Science and Technology | NSF | ENG - Core Programs | 2026 | $19,982,354 | October 1, 2026 | September 30, 2031 | Gerald J Schneider | nsf.gov |
| Cure Sickle Cell | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $19,980,036 | September 28, 2018 | September 30, 2026 | EAPEN, MARY | reporter.nih.gov |
| Vaccine and Treatment Evaluation Units (VTEU) 24-0003 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,949,752 | December 11, 2019 | November 30, 2026 | EL SAHLY, HANA M | reporter.nih.gov |
| Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $19,790,656 | April 10, 2019 | September 30, 2026 | WOLINSKY, STEVEN M | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,720,676 | September 16, 2019 | September 15, 2026 | FRANKENFIELD, JILL | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,528,719 | June 1, 1997 | June 30, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| ADJUVANT COMPARISON AND CHARACTERIZATION | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $19,155,153 | September 1, 2022 | August 31, 2027 | PULENDRAN, BALI | reporter.nih.gov |
| Research Infrastructure: Mid-scale RI-1 (M1:DA): National Connectomics and Ultrastructure Volume Observatory (NCUVO) | NSF | Infrastructure, Institutes, & Centers | 2026 | $18,999,715 | October 1, 2026 | September 30, 2031 | Davi D Bock | nsf.gov |
| Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | NIH | National Cancer Institute | 2021 to 2025 | $18,653,803 | April 1, 1999 | March 31, 2026 | ONAR-THOMAS, ARZU | reporter.nih.gov |
| Research Infrastructure: Mid-scale RI-1 (M1:IP) Genome Infrastructure catalyzing next Generation Antarctic Data, Access, Tools and Analytics | NSF | Office of Polar Programs | 2026 | $18,462,873 | October 1, 2026 | September 30, 2031 | Alison E Murray | nsf.gov |
| ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $18,205,751 | September 19, 2022 | September 18, 2026 | SAUNDERS, KEVIN | reporter.nih.gov |
| Research Infrastructure: Mid-scale RI-1 (M1:IP):National Facility for Ultra-High Sensitivity Solid-State Nuclear Magnetic Resonance Research | NSF | Infrastructure, Institutes, & Centers | 2026 | $17,992,454 | October 1, 2026 | September 30, 2031 | Frederic Mentink-Vigier | nsf.gov |
| NSF-Simons National Institute for Theory and Mathematics in Biology | NSF | Mathematical Science Section | 2023 | $17,750,000 | September 15, 2023 | August 31, 2028 | Antonio Auffinger | nsf.gov |
| Guide RNA manufacturing capabilities for platform in vivo base editing therapies for metabolic liver diseases | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,556,074 | August 1, 2023 | July 31, 2028 | PERANTEAU, WILLIAM H. | reporter.nih.gov |
| Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $17,468,154 | July 5, 2016 | May 31, 2027 | COLLER, BARRY | reporter.nih.gov |
| Immunologic strategies to prevent congenital cytomegalovirus transmission and disease in rhesus monkeys | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,214,484 | July 24, 2019 | May 31, 2029 | PERMAR, SALLIE R. | reporter.nih.gov |
| ALS Efficiently Networking Advanced Beam Line Experiments (ALS-ENABLE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $17,131,931 | September 1, 2017 | August 31, 2027 | ADAMS, PAUL DAVID | reporter.nih.gov |
| Replication Study of Off-Target Assays for Guide RNAs in CRISPR-Based Therapeutics | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $17,077,732 | December 1, 2024 | April 30, 2025 | SAHA, KRISHANU | reporter.nih.gov |
| Emory-CDC CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,972,899 | December 1, 2024 | November 30, 2027 | KELLEY, COLLEEN F | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $16,870,049 | August 4, 1997 | November 30, 2029 | DRAGNEV, KONSTANTIN H. | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) ADMINISTRATIVE COORDINATING CENTER (ACC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $16,650,520 | August 23, 2021 | August 22, 2026 | SHIFFLETT, PATRICIA | reporter.nih.gov |
| UAB Center for AIDS Research (CFAR) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,269,163 | March 1, 1997 | May 31, 2029 | HEFFRON, RENEE A. | reporter.nih.gov |
| RII Track-1: Building Capacity across Iowa to Meet Human Needs from Things that Grow | NSF | Office of Integrative Activities | 2023 | $16,264,658 | August 1, 2023 | July 31, 2028 | Laura R Jarboe | nsf.gov |
| CWRU Center for Excellence on the Impact of Substance Use on HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $16,213,687 | September 15, 2021 | May 31, 2027 | LEVINE, ALAN DAVID | reporter.nih.gov |
| University of Pennsylvania HIV Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,198,927 | February 1, 2007 | November 30, 2027 | FRANK, IAN | reporter.nih.gov |
| BioFoundry: A BioFoundry for Extreme & Exceptional Fungi, Archaea and Bacteria (Ex-FAB) | NSF | Infrastructure, Institutes, & Centers | 2024 | $16,027,294 | September 1, 2024 | August 31, 2030 | Michelle A O'Malley | nsf.gov |
| Alzheimer's Disease Genetics Consortium | NIH | National Institute on Aging | 2021 to 2024 | $15,948,152 | April 1, 2009 | March 31, 2026 | SCHELLENBERG, GERARD DAVID | reporter.nih.gov |
| DEVELOPMENT OF A VACCINE CANDIDATE FOR CORONAVIRUSES | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $15,898,493 | June 1, 2023 | May 31, 2026 | KRAMMER, FLORIAN | reporter.nih.gov |
| Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias | NIH | National Institute on Aging | 2021 to 2025 | $15,514,157 | September 30, 2021 | May 31, 2027 | ELLERBY, LISA M | reporter.nih.gov |
| Therapeutic Editing to Lower PrP in Prion Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $15,507,691 | May 17, 2023 | April 30, 2026 | VALLABH, SONIA MINIKEL | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,471,597 | September 14, 2021 | June 30, 2028 | MADSEN, JOREN C | reporter.nih.gov |
| Pancreatitis-induced initiation of early onset pancreatic cancer | NIH | National Cancer Institute | 2021 to 2025 | $15,447,190 | February 1, 2025 | January 31, 2026 | SHAW, REUBEN | reporter.nih.gov |
| Life Course Cancer Epidemiology Cohort in Women | NIH | National Cancer Institute | 2021 to 2025 | $15,280,631 | June 1, 2013 | August 31, 2028 | ELIASSEN, A. HEATHER | reporter.nih.gov |
| Immune signatures of vaccine responses in vulnerable populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,275,325 | July 12, 2010 | April 30, 2028 | MONTGOMERY, RUTH R | reporter.nih.gov |
| University of Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,173,751 | December 11, 2019 | November 30, 2026 | WALD, ANNA | reporter.nih.gov |
| FSH - an Aging Hormone? | NIH | National Institute on Aging | 2021 to 2025 | $15,166,862 | February 1, 2019 | April 30, 2029 | ZAIDI, MONE | reporter.nih.gov |
| A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $15,144,108 | September 15, 2021 | August 31, 2027 | CLARDY, STACEY LYNN | reporter.nih.gov |
| PHRU-Setshaba Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,110,381 | December 1, 2024 | November 30, 2027 | GRAY, GLENDA E | reporter.nih.gov |
| EXERCISE OPTION PERIOD 1, TASK AREA 5 METABOLOMICS, FOR CORE YEAR 5. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,023,305 | September 25, 2020 | September 24, 2023 | GIBBS, RICHARD | reporter.nih.gov |
| The Alliance NCTN Biorepository and Biospecimen Resource | NIH | National Cancer Institute | 2021 to 2025 | $15,002,332 | May 19, 2015 | March 31, 2027 | WATSON, MARK A. | reporter.nih.gov |
| EXERCISE OPTION PERIOD 1 TO PROVIDE SUPPORT FOR TECHNICAL ASSESSMENTS AND PROJECT MANAGEMENT FOR THE NIBIB RAPID ACCELERATION OF DIAGNOSTICS (RADX) IN | NIH | National Heart, Lung, and Blood Institute | 2021 | $14,996,149 | April 15, 2021 | October 14, 2021 | MARINO, MARK | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| BIOLOGICS IDIQ TASK ORDER- NON-GLP TOXICITY AND TOXICOKINETIC STUDIES IN RODENTS AND NON-RODENTS FOR A NOVEL, SUBCUTANEOUSLY-DOSED MODIFIED-HEPARIN DRUG | NIH | National Institute on Drug Abuse | 2022 to 2025 | $14,836,664 | September 29, 2025 | September 28, 2026 | reporter.nih.gov | |
| NIH SPARC Annual Meeting 2025 | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $14,785,883 | September 10, 2022 | August 31, 2025 | KILGORE, KEVIN L. | reporter.nih.gov |
| Identifying protective omics profiles in centenarians and translating these into preventive and therapeutic strategies | NIH | National Institute on Aging | 2022 to 2025 | $14,689,794 | September 15, 2019 | December 31, 2026 | PERLS, THOMAS T | reporter.nih.gov |
| The UCSC Genome Browser | NIH | National Human Genome Research Institute | 2022 to 2025 | $14,584,394 | July 12, 2001 | April 30, 2027 | HAEUSSLER, MAXIMILIAN | reporter.nih.gov |
| Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks | NIH | National Institute on Aging | 2021 to 2024 | $14,414,001 | September 15, 2020 | August 31, 2025 | THOMPSON, PAUL M | reporter.nih.gov |
| Feasibility of Genomic Newborn Screening Through Public Health Laboratories | NIH | Office of the Director, National Institutes of Health | 2025 | $14,399,393 | September 15, 2025 | September 14, 2028 | GREEN, ROBERT C. | reporter.nih.gov |
| University of Rochester Vaccine and Treatment Evaluation Unit (VTEU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,263,529 | December 11, 2019 | November 30, 2026 | FALSEY, ANN R | reporter.nih.gov |
| Stanford Mendelian Genomics Research Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $14,229,424 | July 15, 2021 | April 30, 2027 | MONTGOMERY, STEPHEN | reporter.nih.gov |
| Kaiser Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,173,633 | December 11, 2019 | November 30, 2026 | JACKSON, LISA A | reporter.nih.gov |
| NIH Tetramer Core Facility for Immunologic and Infectious Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,150,571 | March 21, 2020 | March 20, 2027 | ALTMAN, JOHN | reporter.nih.gov |
| Center for Cancer Immunology and Immunotherapy (CCII) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $14,096,415 | February 1, 2020 | May 31, 2030 | YAN, JUN | reporter.nih.gov |
| The Human Pangenome Reference Consortium Coordination Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $14,064,607 | September 18, 2019 | June 30, 2029 | WANG, TING | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,042,495 | April 1, 2020 | March 31, 2027 | AYE, PYONE | reporter.nih.gov |
| BioFoundry: NSF iBioFoundry for Basic and Applied Biology | NSF | Infrastructure, Institutes, & Centers | 2024 | $13,999,999 | September 1, 2024 | August 31, 2030 | Huimin Zhao | nsf.gov |
| GENCODE: comprehensive gene annotation for human and mouse | NIH | National Human Genome Research Institute | 2021 to 2025 | $13,951,939 | April 1, 2013 | July 31, 2029 | MARTIN, FERGAL JAMES | reporter.nih.gov |
| OUTLAST - A First Multiple-Dose Efficacy Study of IXT-m200, an anti-METH Monoclonal Antibody, in Patients with METH Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2023 | $13,778,020 | September 30, 2021 | July 31, 2025 | STEVENS, MISTY WARD | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,765,907 | April 1, 2020 | March 31, 2027 | VILLINGER, FRANCOIS | reporter.nih.gov |
| Mouse Genome Database (MGD): A Core Knowledge Resource for Functional Characterization of the Human Genome | NIH | National Human Genome Research Institute | 2021 to 2025 | $13,759,338 | July 1, 1997 | June 30, 2026 | BULT, CAROL J | reporter.nih.gov |
| Admin. Supp.: Correction of Neurological Disease via Allele Specific Excision of Pathogenic Repeats | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,703,967 | May 15, 2023 | April 30, 2028 | DOUDNA, JENNIFER A | reporter.nih.gov |
| Multispecies NHP dGTEx Research Center | NIH | National Human Genome Research Institute | 2022 to 2025 | $13,677,402 | August 15, 2022 | May 31, 2027 | CONRAD, DONALD F. | reporter.nih.gov |
| BioFoundry: Glycoscience Resources, Education, And Training (BioF:GREAT) | NSF | Infrastructure, Institutes, & Centers | 2024 | $13,583,372 | September 1, 2024 | August 31, 2030 | Lance Wells | nsf.gov |
| University of Washington (UW) Mendelian Genomics Data Coordinating Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $13,482,792 | June 1, 2021 | March 31, 2027 | MAY, SUSANNE | reporter.nih.gov |
| Protective immunity following dengue virus natural infections and vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,429,941 | July 29, 2015 | July 31, 2030 | HARRIS, EVA | reporter.nih.gov |
| THE PURPOSE OF THIS MODIFICATION IS TO ADD MILESTONE 1A, REVISE THE DELIVERABLES FOR MILESTONE 4-10, AND REVISE THE BASE POP TO END ON 1/18/2022. | NIH | National Heart, Lung, and Blood Institute | 2021 | $13,419,752 | June 8, 2021 | December 21, 2021 | MARINO, MARK | reporter.nih.gov |
| University of Washington Mendelian Genomics Research Center (UW-MGRC) | NIH | National Human Genome Research Institute | 2021 to 2025 | $13,388,168 | June 1, 2021 | March 31, 2027 | WEI, CHIA-LIN | reporter.nih.gov |
| Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,340,237 | April 10, 2020 | November 30, 2026 | MULLIGAN, MARK JOSEPH | reporter.nih.gov |
| University of New Mexico Center for Metals in Biology and Medicine | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $13,321,441 | July 1, 2020 | April 30, 2030 | CAMPEN, MATTHEW J | reporter.nih.gov |
| Kavli Institute for Theoretical Physics | NSF | Physics Section | 2023 | $13,209,636 | August 1, 2023 | July 31, 2028 | Lars Bildsten | nsf.gov |
| A Tolerance Approach to Xenotransplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $13,161,555 | September 15, 2000 | December 31, 2026 | SYKES, MEGAN | reporter.nih.gov |
| BioFoundry: Artificial Intelligence-Driven RNA BioFoundry | NSF | Infrastructure, Institutes, & Centers | 2024 | $13,161,148 | September 1, 2024 | August 31, 2030 | Daeyeon Lee | nsf.gov |
| IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody | NIH | National Institute on Drug Abuse | 2023 to 2025 | $13,125,765 | May 1, 2023 | April 30, 2027 | KALNIK, MATTHEW W | reporter.nih.gov |
| Understanding Influenza and SARS-CoV-2 vaccine responses, in vivo and in vitro | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,884,300 | September 1, 2003 | April 30, 2029 | DAVIS, MARK MORRIS | reporter.nih.gov |
| NSF’s ChemMatCARS: A Synchrotron X-ray National User Facility for Molecular Science at the Advanced Photon Source | NSF | Chemistry Section | 2024 | $12,803,609 | September 1, 2024 | August 31, 2029 | Matthew V Tirrell | nsf.gov |
| Vanderbilt HIV Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,733,650 | February 1, 2007 | November 30, 2027 | HAAS, DAVID W | reporter.nih.gov |
| Case Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,725,521 | December 1, 2024 | November 30, 2027 | YENDEWA, GEORGE | reporter.nih.gov |
| Personalized Modeling of CAR-T Cell Immunotherapy Using iPSC-Derived Effectors and Patient- Derived Tumor Organoids | NIH | National Cancer Institute | 2023 to 2025 | $12,675,268 | March 1, 1997 | August 31, 2026 | LIBUTTI, STEVEN K. | reporter.nih.gov |
| Developmental GTEx Laboratory, Data Analysis and Coordination Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $12,604,407 | September 22, 2021 | June 30, 2027 | ARDLIE, KRISTIN | reporter.nih.gov |
| The Genome Aggregation Database (gnomAD) | NIH | National Human Genome Research Institute | 2021 to 2025 | $12,476,942 | February 8, 2021 | April 2, 2026 | REHM, HEIDI L | reporter.nih.gov |
| The BCM Knockout Mouse Production and Phenotyping Project (BCM KOMP2) | NIH | National Human Genome Research Institute | 2021 to 2025 | $12,471,307 | September 16, 2011 | June 30, 2027 | HEANEY, JASON D. | reporter.nih.gov |
| RAPID ACCELERATION OF DIAGNOTICS (RADX) ADVANCED TECHNOLOGIES PLATFORM RAPID ACCELERATION OF DIAGNOTICS (RADX) ADVANCED TECHNOLOGIES PLATFORM PROJECT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $12,461,593 | July 30, 2020 | April 15, 2022 | LU, JAMES | reporter.nih.gov |
| Columbia Collaborative HIV/AIDS Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,286,513 | February 1, 2007 | November 30, 2027 | SOBIESZCZYK, MAGDALENA ELZBIETA | reporter.nih.gov |
| Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome Function | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,280,909 | April 1, 2021 | June 30, 2026 | LIS, JOHN T | reporter.nih.gov |
| BII: INSITE: Institute for Symbiotic Interactions, Teaching, and Education in the Face of a Changing Climate | NSF | Infrastructure, Institutes, & Centers | 2022 | $12,245,740 | September 1, 2022 | August 31, 2027 | Michele K Nishiguchi | nsf.gov |
| Broad Institute Mendelian Genomic Research Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $12,228,086 | June 1, 2021 | March 31, 2027 | O'DONNELL-LURIA, ANNE | reporter.nih.gov |
| Tissue and organ specific human B cell immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $12,146,380 | April 1, 2019 | March 31, 2025 | LUND, FRANCES E. | reporter.nih.gov |
| Center for Genomic Information Encoded by RNA Nucleotide Modifications | NIH | National Human Genome Research Institute | 2021 to 2025 | $12,143,189 | September 14, 2021 | June 30, 2027 | JAFFREY, SAMIE R | reporter.nih.gov |
| Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,115,898 | December 11, 2019 | November 30, 2026 | FRENCK, ROBERT WILSON | reporter.nih.gov |
| Center for Redox Biology and Cardiovascular Disease | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,065,347 | February 1, 2018 | June 30, 2028 | KEVIL, CHRISTOPHER G | reporter.nih.gov |
| Advancing brain health research through male germline editing in marmosets | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,061,296 | August 1, 2021 | May 31, 2027 | HERMANN, BRIAN PETER | reporter.nih.gov |
| A Safety and Efficacy Study of AAV2-hAADC for AADC Deficiency | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $12,060,518 | September 15, 2016 | August 31, 2027 | BANKIEWICZ, KRYSTOF S | reporter.nih.gov |
| Center for Dynamics and Control of Materials | NSF | Materials Research Section | 2023 | $12,050,000 | September 1, 2023 | August 31, 2029 | Edward T Yu | nsf.gov |
| PDB MANAGEMENT BY THE RESEARCH COLLABORATORY FOR STRUCTURAL BIOINFORMATICS | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $12,006,722 | August 1, 2019 | September 18, 2024 | BURLEY, STEPHEN K | reporter.nih.gov |
| Center for Live Cell Genomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,992,289 | September 15, 2021 | June 30, 2027 | HAUSSLER, DAVID H | reporter.nih.gov |
| The Kansas Institute for Precision Medicine | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,932,398 | February 15, 2019 | March 31, 2029 | GODWIN, ANDREW K. | reporter.nih.gov |
| Technology to understand genetic variant effects in context | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,906,063 | May 8, 2019 | May 31, 2029 | FOWLER, DOUGLAS M | reporter.nih.gov |
| Mid-scale RI-1 (M1: DA): Designing Scalable Community-driven Infrastructure to Support Biodiversity Genomics (SCIBG). | NSF | Infrastructure, Institutes, & Centers | 2026 | $11,876,081 | October 1, 2026 | September 30, 2029 | Erich D Jarvis | nsf.gov |
| Wisconsin MRSEC | NSF | Materials Research Section | 2023 | $11,819,999 | September 1, 2023 | August 31, 2029 | Paul M Voyles | nsf.gov |
| Targeting the B Cell Response to Treat Antibody-Mediated Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,789,092 | August 20, 2021 | May 31, 2028 | KNECHTLE, STUART JOHNSTON | reporter.nih.gov |
| Durable Alteration of the Human Immune system after Infection or Immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,785,761 | June 8, 2009 | May 31, 2029 | CHUNG, RAYMOND T | reporter.nih.gov |
| CEGS: Center for Synthetic Regulatory Genomics - Renewal | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,743,174 | June 12, 2018 | February 29, 2028 | BOEKE, JEF D | reporter.nih.gov |
| Translational Hearing Center | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,739,149 | March 5, 2021 | January 31, 2027 | STEYGER, PETER STEPHEN | reporter.nih.gov |
| Baylor College of Medicine - Mendelian Genomics Research Center (BCM-MGRC) | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,728,929 | July 15, 2021 | April 30, 2027 | GIBBS, RICHARD A | reporter.nih.gov |
| Northwestern University Materials Research Science and Engineering Center | NSF | Materials Research Section | 2023 | $11,700,000 | September 1, 2023 | August 31, 2029 | Mark C Hersam | nsf.gov |
| Materials Research Science and Engineering Center at UCSB | NSF | Materials Research Section | 2023 | $11,700,000 | September 1, 2023 | August 31, 2029 | Ram Seshadri | nsf.gov |
| Materials Research Science and Engineering Centers (MRSEC) UPENN | NSF | Materials Research Section | 2023 | $11,700,000 | September 1, 2023 | August 31, 2029 | Eric A Stach | nsf.gov |
| Center for Musculoskeletal Disease Research (CMDR) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,683,826 | February 16, 2018 | January 31, 2028 | O'BRIEN, CHARLES A | reporter.nih.gov |
| Center for Human Reference Genome Diversity | NIH | National Human Genome Research Institute | 2021 to 2023 | $11,654,820 | September 18, 2019 | September 23, 2024 | MIGA, KAREN HAYDEN | reporter.nih.gov |
| Development of an Optimized Adjuvanted TB Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,645,061 | September 30, 2021 | September 30, 2025 | EVANS, JAY | reporter.nih.gov |
| Cancer Center Support (CORE) Grant | NIH | National Cancer Institute | 2021 to 2025 | $11,628,123 | August 1, 1997 | June 30, 2030 | PALUCKA, ANNA KAROLINA | reporter.nih.gov |
| Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $11,597,222 | December 1, 2024 | November 30, 2025 | DENNY, TOM | reporter.nih.gov |
| Reagent Resource Support Program for AIDS Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,522,629 | April 8, 2018 | April 7, 2025 | FREMONT, VALERIE | reporter.nih.gov |
| Single-cell Mapping Center for Human Regulatory Elements and Gene Activity | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,520,339 | September 1, 2021 | May 31, 2027 | SATPATHY, ANSUMAN | reporter.nih.gov |
| Genomic Characterization of Alzheimer Disease Risk in Admixed Populations with Native American and Southern European Genetic Ancestry | NIH | National Institute on Aging | 2021 to 2025 | $11,411,820 | February 1, 2021 | January 31, 2027 | PERICAK-VANCE, MARGARET A. | reporter.nih.gov |
| Complement Mediated Remodeling in Pulmonary Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $11,355,302 | August 1, 2020 | June 30, 2026 | STENMARK, KURT R. | reporter.nih.gov |
| Characterizing pediatric genomes through an optimized sequencing approach | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $11,335,114 | September 23, 2016 | August 31, 2025 | GRIMWOOD, JANE | reporter.nih.gov |
| Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil | NIH | National Institute on Aging | 2023 to 2025 | $11,334,713 | August 15, 2023 | July 31, 2028 | BENNETT, DAVID ALAN | reporter.nih.gov |
| West African Emerging Infectious Disease Research Center (WA-EIDRC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $11,322,650 | May 21, 2020 | June 5, 2025 | ANDERSEN, KRISTIAN GRAUGAARD | reporter.nih.gov |
| Center for Mouse Genomic Variation at Single Cell Resolution | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,320,491 | August 24, 2021 | May 31, 2027 | MORTAZAVI, SEYED ALI | reporter.nih.gov |
| KwaZulu-Natal Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,302,268 | December 1, 2024 | November 30, 2027 | ABDOOL KARIM, QUARRAISHA | reporter.nih.gov |
| Advancing Transplantation Outcomes in Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,293,854 | July 1, 2025 | June 30, 2028 | BRISCOE, DAVID M. | reporter.nih.gov |
| Center for Pre-Clinical Cancer Research | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,277,290 | March 1, 2021 | February 28, 2027 | FRANCIS, JOSEPH | reporter.nih.gov |
| Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,268,155 | September 1, 2020 | March 31, 2027 | MALINOWSKI, FRANK | reporter.nih.gov |
| Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $11,197,081 | September 30, 2021 | July 31, 2027 | RANA, TARIQ M | reporter.nih.gov |
| Site-Directed RNA Editing of Nav1.7 as a Novel Analgesic | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,194,636 | September 23, 2021 | August 31, 2027 | ROSENTHAL, JOSHUA J.C. | reporter.nih.gov |
| 1/4 Powering Genetic Discovery for Severe Mental Illness in Latin American and African Ancestries | NIH | National Institute of Mental Health | 2021 to 2024 | $11,112,946 | September 14, 2020 | July 31, 2025 | NEALE, BENJAMIN MICHAEL | reporter.nih.gov |
| A Foundational Resource of Functional Elements, TF footprints and Gene Regulatory Interactions | NIH | National Human Genome Research Institute | 2021 to 2025 | $11,067,103 | September 9, 2021 | May 31, 2026 | BUENROSTRO, JASON DANIEL | reporter.nih.gov |
| The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination | NIH | National Human Genome Research Institute | 2021 to 2024 | $11,057,050 | September 22, 2018 | June 30, 2025 | WYATT, CHRISTINA M | reporter.nih.gov |
| BII: Life without water: protecting macromolecules, cells, and organisms during desiccation and rehydration across kingdoms of life | NSF | Infrastructure, Institutes, & Centers | 2024 | $11,052,709 | October 1, 2023 | July 31, 2027 | Seung Y Rhee | nsf.gov |
| Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdose | NIH | National Institute on Drug Abuse | 2022 to 2024 | $11,034,562 | February 1, 2019 | July 31, 2025 | PRAVETONI, MARCO | reporter.nih.gov |
| Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,920,671 | September 6, 2021 | June 30, 2028 | BOIKE, JUSTIN | reporter.nih.gov |
| Advanced Development of a Universal Influenza Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,853,574 | September 9, 2019 | April 24, 2025 | LOCHER, CHRISTOPHER | reporter.nih.gov |
| Increasing the Efficiency of RE-JOIN Through Data Sharing and Integration | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $10,788,004 | September 23, 2022 | July 31, 2027 | LEE, BRENDAN | reporter.nih.gov |
| ZFIN: The Zebrafish Model Organism Database | NIH | National Human Genome Research Institute | 2021 to 2025 | $10,751,162 | July 11, 2003 | August 31, 2026 | WESTERFIELD, MONTE | reporter.nih.gov |
| Scientific Management and Support to the National Institute of Mental Health (NIMH) Repository and Genomics Resource (NRGR) | NIH | National Institute on Drug Abuse | 2025 | $10,685,838 | August 11, 2025 | August 10, 2026 | reporter.nih.gov | |
| Systematic identification of enhancers to target the breadth of excitatory and inhibitory neuronal cell types in the cerebral cortex | NIH | National Institute of Mental Health | 2022 | $10,679,255 | September 1, 2022 | August 31, 2025 | FISHELL, GORDON J | reporter.nih.gov |
| Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,650,296 | September 9, 2019 | October 31, 2025 | CASPER, COREY | reporter.nih.gov |
| BCM CENTER FOR PRECISION MEDICINE MODELS | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $10,593,135 | September 15, 2020 | August 31, 2030 | HEANEY, JASON D. | reporter.nih.gov |
| Administrative Supplement Request for 2025 Systems Biology for Infectious Diseases Annual Meeting | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,511,156 | August 17, 2018 | May 31, 2028 | KROGAN, NEVAN J | reporter.nih.gov |
| Genetic variant-based drug discovery targeting conserved pathways of aging | NIH | National Institute on Aging | 2021 to 2025 | $10,414,630 | September 15, 2017 | August 31, 2028 | VIJG, JAN | reporter.nih.gov |
| SPORE in Brain Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,413,880 | September 1, 2008 | August 31, 2029 | LANG, FREDERICK F | reporter.nih.gov |
| MSK SPORE in Genomic Instability in Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,402,609 | August 13, 2020 | July 31, 2026 | POWELL, SIMON N. | reporter.nih.gov |
| Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. | NIH | National Institute on Aging | 2022 to 2025 | $10,320,460 | February 15, 2022 | January 31, 2027 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Nonhuman Primate (NHP) Core Functional Genomics Laboratory for AIDS Vaccine Research and Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,303,422 | July 1, 2019 | June 30, 2020 | GALE, MICHAEL | reporter.nih.gov |
| Nonhuman Primate Testing Center for Evaluation of Somatic Cell Genome Editing Tools: Antibodies Supplement | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $10,154,758 | April 14, 2023 | March 31, 2025 | TARANTAL, ALICE F | reporter.nih.gov |
| Nonhuman Primate Core Humoral Immunology Laboratory for AIDS Vaccine Research and Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $10,129,006 | March 30, 2024 | March 29, 2025 | SHEN, SHAUNNA | reporter.nih.gov |
| Rat Genome Database | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,063,966 | September 30, 1999 | December 31, 2026 | KWITEK, ANNE E. | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) INFORMATICS RESEARCH CENTER (IRC) YEAR 2 | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $10,031,948 | May 15, 2025 | May 14, 2026 | reporter.nih.gov | |
| Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,931,387 | September 1, 2017 | January 31, 2027 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| The Pacific Northwest Prostate Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $9,924,776 | September 19, 2002 | August 31, 2028 | NELSON, PETER S | reporter.nih.gov |
| The Military HIV Research Program (MHRP) Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,676 | December 10, 2013 | November 30, 2027 | ROBB, MERLIN L | reporter.nih.gov |
| IND-enabling program for a long-acting anti-methamphetamine monoclonal antibody for treating methamphetamine use disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $9,900,251 | September 30, 2022 | July 31, 2025 | STEVENS, MISTY WARD | reporter.nih.gov |
| Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | NIH | National Human Genome Research Institute | 2022 to 2025 | $9,899,998 | August 8, 2017 | May 31, 2027 | WEISSMAN, JONATHAN S. | reporter.nih.gov |
| Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,862,919 | March 22, 2022 | February 28, 2027 | FERNANDEZ-SESMA, ANA | reporter.nih.gov |
| Autism Genetics Phase II: Increasing Representation of Human Diversity | NIH | National Institute of Mental Health | 2021 to 2024 | $9,859,913 | March 25, 2013 | May 31, 2028 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Center: National Synthesis Center for Emergence in the Molecular and Cellular Sciences | NSF | Infrastructure, Institutes, & Centers | 2024 | $9,849,000 | May 1, 2024 | April 30, 2029 | Edward P O'Brien | nsf.gov |
| RARE and Atypical Diabetes Network(RADIANT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $9,843,448 | September 10, 2018 | May 31, 2029 | BALASUBRAMANYAM, ASHOK | reporter.nih.gov |
| UAB Center for Precision Animal Modeling (CPAM) | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,801,687 | September 10, 2020 | August 31, 2030 | YODER, BRADLEY K. | reporter.nih.gov |
| Yale SPORE in Skin Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,801,266 | June 1, 2006 | August 31, 2028 | BOSENBERG, MARCUS W | reporter.nih.gov |
| MIP: Biomaterials, Polymers, and Advanced Constructs from Integrated Chemistry Materials Innovation Platform (BioPACIFIC MIP) | NSF | Materials Research Section | 2025 | $9,800,000 | August 1, 2025 | July 31, 2030 | Javier R Read de Alaniz | nsf.gov |
| Silence ALS: A Platform for the Discovery and Development of Antisense Therapeutics for Patients with Ultra-Rare Forms of ALS | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $9,796,602 | March 1, 2024 | February 28, 2027 | SHNEIDER, NEIL ALAN | reporter.nih.gov |
| Expanded SPF Rhesus Macaque Breeding Colony for AIDS Research | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $9,705,199 | August 1, 2016 | August 31, 2028 | BOHM, RUDOLF PAUL | reporter.nih.gov |
| Dissemination and Coordinating Center for the SCGE Consortium | NIH | National Human Genome Research Institute | 2021 to 2023 | $9,585,373 | February 1, 2019 | November 30, 2025 | DWINELL, MELINDA R | reporter.nih.gov |
| Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer. | NIH | National Cancer Institute | 2022 to 2025 | $9,558,240 | September 20, 2022 | August 31, 2027 | O'REILLY, EILEEN MARY | reporter.nih.gov |
| University of Washington Arboviral Research Network (UWARN) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,499,281 | May 22, 2020 | June 5, 2025 | VAN VOORHIS, WESLEY C | reporter.nih.gov |
| The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN) | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $9,495,667 | September 11, 2018 | July 31, 2028 | ACHENBACH, CHAD J | reporter.nih.gov |
| M-SCORCH: Methamphetamine use disorder data generation center for Single Cell Opioid Responses in the Context of HIV | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,490,616 | May 15, 2021 | February 28, 2027 | HO, YA-CHI | reporter.nih.gov |
| 1/3 Genomics of Schizophrenia in the South African Xhosa | NIH | National Institute of Mental Health | 2021 to 2025 | $9,460,283 | January 1, 2021 | December 31, 2026 | KING, MARY-CLAIRE | reporter.nih.gov |
| Motherhood, pair bonding and parental relatedness as modulators of epigenetic aging | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $9,430,897 | July 10, 2014 | April 30, 2025 | KIARIS, HIPPOKRATIS | reporter.nih.gov |
| Uncovering the Genetic Mechanisms of the Chromosome 17q21.31 Tau Haplotype on Neurodegeneration Risk in FTD and PSP | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,418,230 | September 1, 2021 | August 31, 2026 | GOATE, ALISON M | reporter.nih.gov |
| 1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $9,400,136 | September 1, 2020 | June 25, 2024 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order | NIH | National Institute on Aging | 2021 to 2024 | $9,373,073 | June 1, 2020 | March 31, 2026 | MAYEUX, RICHARD P | reporter.nih.gov |
| Nonhuman Primate Reagent Resource | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,318,044 | September 29, 2016 | March 31, 2027 | MAGNANI, DIOGO | reporter.nih.gov |
| BioSystems Networks and Translational Research - Insights into Inflammation (BioSNTR-II) | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,245,870 | March 20, 2022 | January 31, 2027 | HOPPE, ADAM DAVID | reporter.nih.gov |
| Development of a Novel Therapeutic for Melioidosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,235,577 | September 20, 2022 | September 30, 2026 | ALLEY, M.R.K. (DICKON) | reporter.nih.gov |
| TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) INFORMATICS RESEARCH CENTER (IRC) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $9,225,361 | April 1, 2023 | March 31, 2024 | ABECASIS, GONCALO | reporter.nih.gov |
| Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $9,218,182 | August 24, 2022 | July 31, 2027 | BARKER, BRIDGET MARIE | reporter.nih.gov |
| MoTrPAC Genomics, Epigenomics and Transcriptomics Chemical Analysis Site Supplement | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,131,090 | June 1, 2025 | May 31, 2027 | SEALFON, STUART C. | reporter.nih.gov |
| GEARs Combining advances in Genomics and Environmental science to accelerate Actionable Research and practice in ASD | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $9,120,320 | September 6, 2022 | August 31, 2027 | VOLK, HEATHER E | reporter.nih.gov |
| Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,106,321 | September 29, 2021 | August 31, 2026 | DONNELLY, CHRISTOPHER JAMES | reporter.nih.gov |
| Inherited T cell defects: Diagnosis, Mechanisms and Treatments | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,040,281 | September 8, 2020 | August 31, 2025 | MARSON, ALEXANDER | reporter.nih.gov |
| Center: InnovATEBIO The National Biotechnology Education Center | NSF | Workforce & Talent Continuum Section | 2024 | $8,888,649 | September 1, 2024 | August 31, 2029 | Linnea A Fletcher | nsf.gov |
| The Mutant Mouse Resource and Research Center at the University of Missouri | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $8,888,200 | May 1, 2000 | February 28, 2030 | AMOS-LANDGRAF, JAMES | reporter.nih.gov |
| High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular Phenotypes | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,874,835 | September 1, 2021 | May 31, 2027 | GERSBACH, CHARLES A. | reporter.nih.gov |
| Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,752,600 | June 1, 2021 | May 31, 2026 | DAVIGLUS, MARTHA L | reporter.nih.gov |
| Multiscale functional characterization of genomic variation in human developmental disorders | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,736,987 | September 1, 2021 | May 31, 2027 | HON, GARY CHUNG | reporter.nih.gov |
| Statistical Methods for Integrative Genomics in Cancer | NIH | National Cancer Institute | 2021 to 2025 | $8,721,062 | July 1, 2016 | August 31, 2027 | GAUDERMAN, WILLIAM JAMES | reporter.nih.gov |
| Stanford Center for Connecting DNA Variants to Function and Phenotype | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,717,486 | September 3, 2021 | May 31, 2026 | ENGREITZ, JESSE M | reporter.nih.gov |
| Therapeutic gene editing and multimodal imaging in juvenile macular degeneration | NIH | National Eye Institute | 2021 to 2024 | $8,710,741 | June 1, 2020 | May 31, 2026 | TSANG, STEPHEN H | reporter.nih.gov |
| Risk Factors, Pathology, and Clinical Expressions of AD | NIH | National Institute on Aging | 2021 to 2024 | $8,703,055 | July 15, 1998 | April 30, 2026 | BENNETT, DAVID ALAN | reporter.nih.gov |
| Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $8,683,509 | September 30, 2022 | July 31, 2025 | TOLL, LAWRENCE R | reporter.nih.gov |
| Tools for gene editing in marmosets | NIH | National Institute on Drug Abuse | 2022 to 2025 | $8,672,011 | September 1, 2022 | June 30, 2027 | WANG, XIAOQIN | reporter.nih.gov |
| Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,671,281 | September 1, 2021 | May 31, 2027 | PINELLO, LUCA | reporter.nih.gov |
| Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Human Genotype-Tissue Expression Project | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,668,711 | September 22, 2021 | June 30, 2027 | SESTAN, NENAD | reporter.nih.gov |
| Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions | NIH | National Institute on Aging | 2021 to 2025 | $8,654,669 | July 1, 2021 | June 30, 2027 | TEMPLE, SALLY | reporter.nih.gov |
| Task V34: Master Cell Banks Manufacturing for Next Generation SARS-CoV-2 Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $8,647,922 | May 15, 2018 | May 14, 2028 | TRUSHEIM, HEIDI | reporter.nih.gov |
| RADX PROGRAM: TECH PROJECT NO 6114 FLUIDIGM ADVANTA DX SARS-COV-2 RT-PCR ASSAY FOR SALIVA | NIH | National Heart, Lung, and Blood Institute | 2021 | $8,580,056 | July 30, 2020 | September 30, 2021 | QUONG, ANDREW | reporter.nih.gov |
| Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,478,988 | April 1, 2020 | March 31, 2027 | LEWIS, MARK | reporter.nih.gov |
| PIPP Phase II: Community Empowering Pandemic Prediction and Prevention from Atoms to Societies (COMPASS) | NSF | Infrastructure, Institutes, & Centers | 2024 | $8,400,000 | September 1, 2024 | August 31, 2031 | T M Murali | nsf.gov |
| PIPP Phase II: Center for Pandemic Insights (CPI) | NSF | Infrastructure, Institutes, & Centers | 2024 | $8,400,000 | September 1, 2024 | August 31, 2031 | Christine K Johnson | nsf.gov |
| PIPP Phase II: Environmental Surveillance for Assessing Pathogen Emergence (ESCAPE) | NSF | Infrastructure, Institutes, & Centers | 2024 | $8,399,997 | September 1, 2024 | August 31, 2031 | Scott Berry | nsf.gov |
| Utilization of Advanced Technologies for the Understanding of Human Structural Birth Defects | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $8,390,717 | January 11, 2021 | December 31, 2025 | BEIER, DAVID R. | reporter.nih.gov |
| Xenbase: a Xenopus Model Organism Knowledgebase | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $8,386,093 | June 1, 2010 | April 30, 2026 | ZORN, AARON M | reporter.nih.gov |
| ImmGen: Gene Expression and Regulation in Immune Cells | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,377,460 | September 18, 2007 | August 31, 2027 | BENOIST, CHRISTOPHE O. | reporter.nih.gov |
| Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models | NIH | National Institute on Aging | 2021 to 2025 | $8,376,812 | July 1, 2021 | June 30, 2026 | SHULMAN, JOSHUA M | reporter.nih.gov |
| Genetic Studies of Alzheimer's Disease in Jewish and Arab Populations | NIH | National Institute on Aging | 2023 to 2025 | $8,372,205 | September 1, 2023 | August 31, 2028 | FARRER, LINDSAY A. | reporter.nih.gov |
| San Francisco Bay Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,314,128 | March 2, 2007 | November 30, 2027 | BUCHBINDER, SUSAN | reporter.nih.gov |
| Multi-omic functional assessment of novel AD variants using high-throughput and single-cell technologies | NIH | National Institute on Aging | 2021 to 2025 | $8,305,058 | July 1, 2021 | June 30, 2026 | MONTINE, THOMAS J | reporter.nih.gov |
| A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $8,293,749 | September 30, 2021 | August 31, 2026 | ZAIDI, MONE | reporter.nih.gov |
| Washington University Intellectual and Developmental Disabilities Research Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $8,281,463 | July 28, 2020 | May 31, 2027 | DOUGHERTY, JOSEPH D | reporter.nih.gov |
| Consortia for Innovative AIDS Research in Nonhuman Primates | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $8,268,168 | May 1, 2016 | April 30, 2022 | BAROUCH, DAN H. | reporter.nih.gov |
| Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials | NIH | National Institute on Drug Abuse | 2022 | $8,267,350 | September 30, 2022 | September 29, 2025 | PRAVETONI, MARCO | reporter.nih.gov |
| Polygenic Risk Score Methods Development Consortium Coordinating Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,262,832 | June 8, 2021 | March 31, 2027 | RICE, KENNETH M. | reporter.nih.gov |
| Comprehensive Somatic Variant Characterization at the HGSC | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,249,999 | May 1, 2023 | April 30, 2026 | GIBBS, RICHARD A | reporter.nih.gov |
| Manufacturing of Drug Product, Dual Aβ/tau Vaccine for Clinical Trials | NIH | National Institute on Aging | 2021 to 2023 | $8,244,109 | February 1, 2019 | January 31, 2025 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,243,787 | August 15, 2021 | June 30, 2027 | FOX, HOWARD S | reporter.nih.gov |
| National eXtreme Ultrafast Science (NeXUS) Operation & Maintenance | NSF | Chemistry Section | 2024 | $8,235,263 | October 1, 2024 | September 30, 2029 | Lawrence R Baker | nsf.gov |
| Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $8,189,971 | September 15, 2024 | August 31, 2026 | GITLER, AARON D. | reporter.nih.gov |
| NICHD PEDIATRIC AND MATERNAL RESOURCE CENTER: BRIDGING PHARMACOLOGY AND THE REAL WORLD - BPCA PTN | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $8,177,199 | September 23, 2024 | September 22, 2028 | BENJAMIN, DANIEL | reporter.nih.gov |
| WormBase: a core data resource for C. elegans and other nematodes | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,167,100 | July 20, 2000 | June 30, 2028 | STERNBERG, PAUL WARREN | reporter.nih.gov |
| A deep longitudinal analysis of next generation influenza vaccines in older adults | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $8,127,184 | January 1, 2022 | December 31, 2026 | UCAR, DUYGU | reporter.nih.gov |
| Center for Personal Dynamic Regulomes | NIH | National Human Genome Research Institute | 2021 to 2023 | $8,095,826 | September 1, 2014 | June 30, 2024 | CHANG, HOWARD Y | reporter.nih.gov |
| The Psychiatric Cell Map Initiative: Connecting Genomics, Subcellular Networks, and Higher Order Phenotypes | NIH | National Institute of Mental Health | 2021 to 2022 | $8,086,271 | September 5, 2018 | June 30, 2023 | KROGAN, NEVAN J | reporter.nih.gov |
| Massively parallel characterization of variants and elements impacting transcriptional regulation in dynamic cellular systems | NIH | National Human Genome Research Institute | 2021 to 2025 | $8,077,896 | September 1, 2021 | May 31, 2027 | SHENDURE, JAY ASHOK | reporter.nih.gov |
| Human Biomimetics for Mucosal Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,059,968 | March 15, 2015 | May 31, 2027 | ESTES, MARY KOLB | reporter.nih.gov |
| Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for Schizophrenia | NIH | National Institute of Mental Health | 2021 to 2025 | $8,050,699 | April 1, 2021 | January 31, 2027 | CRAWFORD, GREGORY E | reporter.nih.gov |
| cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $8,013,603 | August 30, 2022 | August 29, 2030 | HASSELL, THOMAS | reporter.nih.gov |
| Genomic risk in clinical care to promote preventive health in New York City patients | NIH | National Human Genome Research Institute | 2021 to 2025 | $7,984,720 | July 1, 2020 | April 30, 2027 | KENNY, EIMEAR ELIZABETH | reporter.nih.gov |
| Stanford MoTrPAC Site for Genomes, Epigenomes and Transcriptomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,914,745 | December 13, 2016 | May 31, 2027 | SNYDER, MICHAEL P. | reporter.nih.gov |
| Diabetes Research Center (DRC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,913,084 | December 1, 2002 | June 30, 2028 | SALTIEL, ALAN R. | reporter.nih.gov |
| External Quality Assurance Program Oversight Laboratory (EQAPOL) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $7,902,910 | September 30, 2024 | September 29, 2031 | DENNY, THOMAS | reporter.nih.gov |
| Precision IBD via genetics and genomics: integrating International and multi-omic datasets, expanding studies in diverse populations, and defining mechanisms of unmet clinical needs in IBD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,890,535 | September 30, 2002 | June 30, 2027 | CHO, JUDY H. | reporter.nih.gov |
| BII: Evolving Meta-Ecosystems in the Arctic | NSF | Infrastructure, Institutes, & Centers | 2024 | $7,871,344 | April 1, 2024 | March 31, 2030 | Linda A Deegan | nsf.gov |
| Restoring Vision with High-Fidelity Nonsense Codon Correction | NIH | National Eye Institute | 2021 to 2025 | $7,812,597 | February 1, 2021 | November 30, 2026 | PATTNAIK, BIKASH RANJAN | reporter.nih.gov |
| Advanced Development and Clinical Evaluation of an Entamoeba Histolytica Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $7,788,182 | September 21, 2018 | November 22, 2025 | FOX, CHRISTOPHER | reporter.nih.gov |
| Stanford Tissue Mapping Center | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,785,758 | September 23, 2022 | June 30, 2026 | SNYDER, MICHAEL P. | reporter.nih.gov |
| Integrating innate and adaptive pathways in vaccine responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $7,762,589 | April 1, 2014 | March 31, 2024 | RAVETCH, JEFFREY VICTOR | reporter.nih.gov |
| Seattle Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,698,581 | February 1, 2007 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| JAX MorPhiC Data Production Center | NIH | National Human Genome Research Institute | 2022 to 2025 | $7,698,185 | August 4, 2022 | May 31, 2027 | ROBSON, PAUL | reporter.nih.gov |
| A biochemical roadmap of exercise signal | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,628,641 | June 1, 2025 | May 31, 2027 | GERSZTEN, ROBERT E | reporter.nih.gov |
| Center: NSF Center for Synthetic Organic Electrochemistry | NSF | Chemistry Section | 2025 | $7,600,000 | September 1, 2025 | August 31, 2030 | Shelley D Minteer | nsf.gov |
| BII: EMBER: Embedding Molecular Biology in Ecosystem Research in an era of increasing wildfire and drought | NSF | Infrastructure, Institutes, & Centers | 2024 | $7,541,614 | May 1, 2024 | April 30, 2030 | Tara Hudiburg | nsf.gov |
| Parkinsons Disease Scalable iPSC Autologous Cell Therapy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $7,528,144 | January 1, 2020 | December 31, 2025 | HALLETT, PENELOPE JANE | reporter.nih.gov |
| Structural Dynamics at LCLS | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $7,526,067 | April 1, 2021 | March 31, 2026 | BOUTET, SEBASTIEN | reporter.nih.gov |
| Small RNAs as Novel Modulators of Microbe-Host Interactions | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $7,525,895 | September 1, 2021 | April 30, 2027 | GITAI, ZEMER | reporter.nih.gov |
| Plasma Proteomic Signatures for Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 | $7,523,227 | September 15, 2022 | August 31, 2025 | SHADYAB, ALADDIN | reporter.nih.gov |
| Ad26 Based Therapeutic Vaccines for HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,518,476 | May 12, 2020 | April 30, 2027 | BAROUCH, DAN H. | reporter.nih.gov |
| NSF IMPACT Engine in Indiana | NSF | Regional Innovation Section | 2026 | $7,500,000 | August 1, 2026 | July 31, 2036 | James G Lancaster | nsf.gov |
| QLCI: Quantum Sensing for Biophysics and Bioengineering (QUBBE) | NSF | MPS - Core Programs | 2026 | $7,500,000 | September 1, 2026 | August 31, 2031 | Gregory S Engel | nsf.gov |
| NSF NEO-SMART Engine in Northeast Ohio | NSF | Regional Innovation Section | 2026 | $7,499,984 | August 1, 2026 | July 31, 2036 | Nicholas Barendt | nsf.gov |
| NSF RuralSTAMINA Biomanufacturing Engine in Iowa and Nebraska | NSF | Regional Innovation Section | 2026 | $7,499,902 | August 1, 2026 | July 31, 2036 | Kevin M Moore | nsf.gov |
| SUPPLEMENTAL FUNDS TO PROVIDE RADX INFRASTRUCTURE SUPPORT THROUGH JULY 1, 2021 | NIH | National Heart, Lung, and Blood Institute | 2021 | $7,499,311 | July 2, 2020 | April 30, 2021 | MARINO, MARK | reporter.nih.gov |
| NSF BRIDGES Engine in Alabama and Tennessee | NSF | Regional Innovation Section | 2026 | $7,494,144 | August 1, 2026 | July 31, 2036 | Samuel W Jackson | nsf.gov |
| Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $7,486,964 | February 15, 2020 | January 31, 2026 | ROUSSOS, PANAGIOTIS | reporter.nih.gov |
| Bridging the gap between type 2 diabetes GWAS and therapeutic targets | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $7,480,415 | August 20, 2020 | June 30, 2026 | MOHLKE, KAREN L. | reporter.nih.gov |
| Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates | NIH | National Institute on Drug Abuse | 2023 to 2025 | $7,434,979 | June 1, 2023 | February 29, 2028 | RANA, TARIQ M | reporter.nih.gov |
| Biogenesis and Catabolism of Atherogenic Lipoproteins | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,418,574 | May 1, 2023 | April 30, 2028 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Advanced Development of Vaccines for Filoviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,417,867 | July 21, 2020 | December 31, 2026 | ELDRIDGE, JOHN | reporter.nih.gov |
| Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $7,369,853 | September 23, 2021 | February 28, 2025 | ALEM, FARHANG | reporter.nih.gov |
| Strategies to Optimize Pig-to-Primate Kidney Xenograft Survival | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,360,026 | July 1, 2016 | June 30, 2030 | ADAMS, ANDREW B | reporter.nih.gov |
| Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,354,954 | May 15, 2023 | April 30, 2028 | COLECRAFT, HENRY M. | reporter.nih.gov |
| Genomic Resource for the Yeast Saccharomyces | NIH | National Human Genome Research Institute | 2021 to 2025 | $7,354,502 | September 30, 1995 | February 28, 2026 | SHERLOCK, GAVIN J | reporter.nih.gov |
| Institute for Mathematical and Statistical Innovation | NSF | Mathematical Science Section | 2025 | $7,325,525 | August 1, 2025 | July 31, 2030 | Kevin D Corlette | nsf.gov |
| Open-Access AAV Toolbox for Basal Ganglia Cell Types and Circuits | NIH | National Institute of Mental Health | 2021 | $7,282,237 | September 16, 2021 | September 15, 2024 | TASIC, BOSILJKA | reporter.nih.gov |
| DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $7,281,050 | September 30, 2023 | September 29, 2028 | EL-KAMMASH, BRUXANNE | reporter.nih.gov |
| ProMoTr: A Proteomics Center for MoTrPAC | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,272,520 | December 8, 2016 | May 31, 2027 | ADKINS, JOSHUA N. | reporter.nih.gov |
| Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $7,269,328 | March 15, 2023 | February 29, 2028 | DULAI, PARAMBIR SINGH | reporter.nih.gov |
| Pregnant Female Reproductive Tissue Mapping Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $7,253,038 | August 1, 2022 | July 31, 2027 | LAURENT, LOUISE CHANG | reporter.nih.gov |
| Specific Pathogen Free 18 Baboon Research Resource (SPF18BRR) | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $7,246,135 | August 15, 2017 | April 30, 2028 | HOPKINS, WILLIAM D | reporter.nih.gov |
| Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging | NIH | National Institute on Aging | 2022 to 2025 | $7,239,829 | August 15, 2022 | June 30, 2027 | CRUCHAGA, CARLOS | reporter.nih.gov |
| RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT NO 2375 - MASSIVELY PARALLEL CENTRALIZED AND DECENTRALIZED ULTRAFAST COVID-19INFECTIOUS | NIH | National Heart, Lung, and Blood Institute | 2021 | $7,200,049 | September 30, 2020 | September 29, 2021 | BEEBE, DAVID | reporter.nih.gov |
| Identifying Immune and Epithelial Network Signatures in Very Early Onset Inflammatory Bowel Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $7,187,152 | September 15, 2020 | June 30, 2026 | SNAPPER, SCOTT B | reporter.nih.gov |
| Washington University Omics Production Center | NIH | National Human Genome Research Institute | 2023 to 2024 | $7,183,550 | September 12, 2023 | May 31, 2028 | PATTI, GARY J | reporter.nih.gov |
| Adjuvant Development of the TLR4 Ligand BECC470s For Use in Influenza, S. aureus, and P. aeruginosa Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $7,143,498 | September 30, 2023 | September 29, 2028 | SORENSON, GREGORY | reporter.nih.gov |
| Developing a P4 Medicine Approach to Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,129,816 | July 1, 2023 | June 30, 2028 | PACK, ALLAN I | reporter.nih.gov |
| Coordinating center for the NCI small cell lung cancer research consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,127,674 | June 24, 2022 | May 31, 2027 | RUDIN, CHARLES M. | reporter.nih.gov |
| Integrative Multidisciplinary Discovery Platform to Unlock Marine Natural Products Therapeutic Opportunities | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $7,069,063 | August 1, 2022 | July 31, 2027 | LUESCH, HENDRIK | reporter.nih.gov |
| Swine Somatic Cell Genome Editing (SCGE) Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $7,052,414 | June 1, 2019 | May 31, 2025 | WELLS, KEVIN DALE | reporter.nih.gov |
| iCAN PREVENT: MD Anderson International Cancer Prevention Clinical Trials Consortium | NIH | National Cancer Institute | 2021 to 2025 | $7,046,172 | August 15, 2019 | July 31, 2031 | VILAR SANCHEZ, EDUARDO | reporter.nih.gov |
| Institute for Pure and Applied Mathematics | NSF | Mathematical Science Section | 2026 | $7,039,283 | December 1, 2025 | November 30, 2030 | Dimitri Y Shlyakhtenko | nsf.gov |
| Genomic control of gene regulatory networks governing early human lineage decisions | NIH | National Human Genome Research Institute | 2021 to 2025 | $7,036,239 | August 19, 2021 | May 31, 2026 | HUANGFU, DANWEI | reporter.nih.gov |
| Trio Analysis of Recurrent Pregnancy Loss Integrated Bioinformatics Genomics Study (TRIOS) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $7,034,759 | May 15, 2021 | March 31, 2027 | LATHI, RUTH B | reporter.nih.gov |
| TASK ORDER B-15: Model Development and Medical Countermeasure Evaluation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $7,029,612 | October 24, 2022 | October 1, 2023 | GRIFFITHS, ANTHONY | reporter.nih.gov |
| National Center for Quantitative Biology of Complex Systems | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $7,028,847 | July 5, 2016 | June 30, 2026 | COON, JOSHUA J | reporter.nih.gov |
| Exosomes as mediators of cardiac injury and repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,022,243 | September 1, 2017 | June 30, 2029 | KISHORE, RAJ | reporter.nih.gov |
| Dana-Farber/Harvard Cancer Center Experimental Therapeutics Clinical Trials Network Site (DF/HCC ETCTN Site) | NIH | National Cancer Institute | 2021 to 2025 | $7,018,946 | March 13, 2014 | February 28, 2027 | SHAPIRO, GEOFFREY I. | reporter.nih.gov |
| Autism Genetics Phase II: Increasing Representation of Human Diversity | NIH | National Institute of Mental Health | 2025 | $7,009,385 | March 25, 2013 | May 31, 2028 | GESCHWIND, DANIEL H | reporter.nih.gov |
| Functional Interrogation of T2D-associated genes in human stem cell-derived models and mice | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,998,766 | August 20, 2020 | June 30, 2025 | SEALE, PATRICK | reporter.nih.gov |
| NSF-BII: Integrative Movement Sciences Institute | NSF | Infrastructure, Institutes, & Centers | 2024 | $6,952,937 | March 1, 2024 | February 28, 2030 | Monica A Daley | nsf.gov |
| ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,937,118 | September 30, 2023 | September 29, 2026 | COLLINS, NICOLAS | reporter.nih.gov |
| Primary Open Angle African-American Glaucoma Genetics Study Renewal | NIH | National Eye Institute | 2021 to 2025 | $6,924,827 | April 1, 2014 | March 31, 2026 | O'BRIEN, JOAN M | reporter.nih.gov |
| Whole Individual Comprehensive KnowlEDge: Somatic Mosaicism across Human Tissues (WICKed SMaHT) | NIH | National Institute on Drug Abuse | 2023 to 2025 | $6,922,231 | May 1, 2023 | April 30, 2026 | ARDLIE, KRISTIN | reporter.nih.gov |
| Functional genomic studies in diverse populations to characterize risk loci for Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,908,458 | July 15, 2021 | June 30, 2027 | VANCE, JEFFERY MARVIN | reporter.nih.gov |
| NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCE (NCATS), BESPOKE GENE THERAPY CONSORTIUM, COORDINATION CENTER, GENE THERAPY ASSET DEVELOPMENT AND PLATFORM OPERA | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $6,908,005 | July 2, 2024 | August 31, 2026 | reporter.nih.gov | |
| BII: Predicting the global host-virus network from molecular foundations | NSF | Infrastructure, Institutes, & Centers | 2025 | $6,899,962 | October 1, 2024 | August 31, 2027 | Colin J Carlson | nsf.gov |
| The NINDS Human Cell and Data Repository (U24 renewal) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,898,547 | September 30, 2015 | July 31, 2030 | KNOWLES, JAMES A | reporter.nih.gov |
| Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,892,629 | September 15, 2004 | August 31, 2025 | FARRIS, A DARISE | reporter.nih.gov |
| Personalized prime editing as a platform for hepatic inborn errors of metabolism | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $6,886,793 | September 20, 2024 | August 31, 2028 | AHRENS-NICKLAS, REBECCA CLARE | reporter.nih.gov |
| Cell type specific AAVs to study reward and cognition | NIH | National Institute of Mental Health | 2022 | $6,850,168 | September 1, 2022 | August 31, 2025 | STAUFFER, WILLIAM RICHARD | reporter.nih.gov |
| Resuscitation Strategies for Achieving Thrombo-inflammatory Homeostasis | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $6,845,824 | May 20, 2019 | April 30, 2026 | COHEN, MITCHELL | reporter.nih.gov |
| Native-like Envelope Trimer Therapeutic Vaccination for Induction of Broadly Neutralizing Antibodies to Facilitate HIV Functional Cure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,813,637 | April 14, 2020 | July 31, 2027 | RIDDLER, SHARON | reporter.nih.gov |
| The Mutant Mouse Resource and Research Center at The Jackson Laboratory | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $6,802,936 | January 1, 2010 | January 31, 2030 | LUTZ, CATHLEEN M | reporter.nih.gov |
| Center for Mesoscale Mapping | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,740,828 | August 1, 2020 | May 31, 2030 | ROSEN, BRUCE R | reporter.nih.gov |
| Development of a COVID-19 Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $6,733,518 | September 1, 2020 | October 31, 2023 | REED, STEVEN | reporter.nih.gov |
| Lyme Disease: B cell epitope discovery and mechanisms of antibody protection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,722,146 | September 16, 2019 | September 15, 2024 | MANTIS, NICHOLAS J. | reporter.nih.gov |
| Tissue Engineering Resource Center | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,721,905 | September 16, 2019 | February 28, 2029 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| PROMINENT - UCSF | NIH | National Cancer Institute | 2022 to 2025 | $6,721,823 | June 22, 2022 | May 31, 2026 | BALMAIN, ALLAN | reporter.nih.gov |
| B and T Cell Biology of Protection from and Eradication of SIV/SHIV Infection - Administrative Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $6,714,942 | June 1, 2016 | May 31, 2022 | HUNTER, ERIC | reporter.nih.gov |
| An Intranasal GDNF Gene Therapy for Opioid Relapse Reduction | NIH | National Institute on Drug Abuse | 2021 | $6,693,512 | September 15, 2021 | August 31, 2025 | WASZCZAK, BARBARA LEE | reporter.nih.gov |
| Emerging infections: surveillance, epidemiology and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,690,286 | May 11, 2020 | June 5, 2025 | WANG, DAVID | reporter.nih.gov |
| Making antibody generation rapid, scalable, and democratic through machine learning and continuous evolution | NIH | National Cancer Institute | 2021 to 2024 | $6,686,758 | September 10, 2020 | August 31, 2025 | LIU, CHANG C | reporter.nih.gov |
| Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,685,272 | April 11, 2022 | March 31, 2027 | BAR, KATHARINE JUNE | reporter.nih.gov |
| Aurum Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,678,965 | December 1, 2020 | November 30, 2027 | CHURCHYARD, GAVIN JOHN | reporter.nih.gov |
| A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,678,063 | May 1, 2019 | April 30, 2025 | RADOLF, JUSTIN D | reporter.nih.gov |
| Administrative Supplement for Upgrading the University of Pittsburgh Regional Biocontainment Laboratory within The Center for Vaccine Research | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $6,659,737 | August 22, 2022 | February 28, 2025 | DUPREX, WILLIAM PAUL | reporter.nih.gov |
| B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,634,396 | September 16, 2023 | September 15, 2024 | FREMONT, DAVED | reporter.nih.gov |
| EHR-based Genome-Informed Risk Assessment and Communication | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,633,680 | August 8, 2025 | April 30, 2026 | WENG, CHUNHUA | reporter.nih.gov |
| Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,612,767 | September 21, 2022 | January 18, 2026 | KRUISWIJK, CORINE | reporter.nih.gov |
| Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $6,612,268 | September 30, 2021 | January 31, 2026 | CAMPBELL, JAMES N | reporter.nih.gov |
| Cell Specific Perturbations of the Proteome in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,610,744 | September 30, 2021 | July 31, 2027 | YATES III, JOHN R | reporter.nih.gov |
| Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,605,926 | December 9, 2021 | November 30, 2026 | LENG, SEAN XIAO | reporter.nih.gov |
| Technology Development Coordinating Center | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,597,721 | May 20, 2021 | February 28, 2030 | ADAMS, MARK D | reporter.nih.gov |
| Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,592,393 | September 23, 2022 | July 22, 2026 | NORTON, ELIZABETH | reporter.nih.gov |
| Precision Editing of Granulin Mutations that Cause Frontotemporal Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $6,580,415 | August 15, 2025 | July 31, 2029 | SONTHEIMER, ERIK J. | reporter.nih.gov |
| Spatial multiomic mapping of gene function with CRISPRoff | NIH | National Human Genome Research Institute | 2022 to 2025 | $6,562,020 | September 1, 2022 | June 30, 2027 | GILBERT, LUKE | reporter.nih.gov |
| Technology to Realize the Full Potential of UHF MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,553,989 | February 1, 2019 | January 31, 2029 | METZGER, GREGORY JOHN | reporter.nih.gov |
| Task A68: Screening Vaccine (and Other Biologics) Platform Technologies using Coronavirus Mouse Immunogenicity as a Model System | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,550,363 | May 23, 2022 | September 30, 2026 | GRAHAM, RACHEL | reporter.nih.gov |
| AAV-mediated editing to treat human autosomal dominant hearing loss DFNA41 and DFNA2 | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $6,541,622 | September 20, 2024 | August 31, 2028 | CHEN, ZHENG-YI | reporter.nih.gov |
| An in integrated platform for multiomic analyses of pathogen and host data using scalable public infrastructure | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $6,532,864 | July 18, 2024 | June 30, 2029 | NEKRUTENKO, ANTON | reporter.nih.gov |
| Stellenbosch University Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,524,563 | April 15, 2007 | November 30, 2027 | HESSELING, ANNEKE CATHARINA | reporter.nih.gov |
| Creation and Repair of Postreplicative DNA Gaps | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $6,486,544 | May 15, 2019 | July 31, 2028 | COX, MICHAEL M. | reporter.nih.gov |
| Yale Liver Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,469,647 | September 30, 1997 | June 16, 2026 | NATHANSON, MICHAEL H | reporter.nih.gov |
| Small-molecule activators of STING-signaling as novel adjuvants for flavivirus vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,461,817 | September 30, 2019 | September 29, 2024 | NELSON, JAY | reporter.nih.gov |
| Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,461,018 | August 9, 2022 | May 31, 2027 | HERSCHHORN, ALON | reporter.nih.gov |
| From proteins to cells to tissues: A multi-scale assessment of biomechanical regulation by the myosin molecular motor | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $6,459,020 | May 15, 2019 | April 30, 2025 | BERNSTEIN, DANIEL | reporter.nih.gov |
| PIPP Phase II: Analysis and Prediction of Pandemic Expansion (APPEX) | NSF | Infrastructure, Institutes, & Centers | 2026 | $6,430,848 | October 1, 2025 | August 31, 2031 | Nina H Fefferman | nsf.gov |
| Molecular Circuits in the Hematopoietic Stem Cell Niche | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $6,422,507 | August 15, 2020 | May 31, 2025 | DALEY, GEORGE Q | reporter.nih.gov |
| University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $6,406,743 | August 1, 2019 | July 31, 2025 | WALD, ANNA | reporter.nih.gov |
| Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,398,428 | July 1, 2021 | June 30, 2027 | GENGENBACHER, MARTIN ALFONS | reporter.nih.gov |
| CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan | NIH | National Cancer Institute | 2023 to 2025 | $6,381,605 | September 22, 2021 | August 31, 2027 | FRIEDMAN, DEBRA L. | reporter.nih.gov |
| Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL | NIH | National Institute on Aging | 2022 to 2025 | $6,381,039 | September 1, 2022 | May 31, 2027 | HAINES, JONATHAN L | reporter.nih.gov |
| Biomarker Rich Clinical Trial of an Innovative Antibody Antagonist of TNFR2 in Non-Hodgkin Lymphoma Featuring Cutaneous T Cell Lymphoma (CTCL). | NIH | National Cancer Institute | 2021 to 2025 | $6,371,380 | September 1, 2021 | June 30, 2027 | BROOKS, DAVID G | reporter.nih.gov |
| American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,361,142 | July 20, 2020 | May 31, 2025 | HARRIS, EVA | reporter.nih.gov |
| Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,355,182 | February 1, 2022 | December 31, 2027 | TANTISIRA, KELAN G | reporter.nih.gov |
| Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,798 | August 20, 2021 | May 31, 2027 | LESLIE, CHRISTINA S | reporter.nih.gov |
| The impact of genomic variation on environment-induced changes in pancreatic beta cell states | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,795 | September 7, 2021 | May 31, 2027 | CARTER, HANNAH KATHRYN | reporter.nih.gov |
| BII: Polyploidy: Integration Across Scales and Biological Systems | NSF | Infrastructure, Institutes, & Centers | 2024 | $6,345,720 | June 1, 2024 | May 31, 2030 | Pamela S Soltis | nsf.gov |
| Pediatric Mendelian Genomics Research Center | NIH | National Human Genome Research Institute | 2023 to 2025 | $6,331,078 | June 1, 2021 | March 31, 2027 | VILAIN, ERIC J. | reporter.nih.gov |
| Biologically informed design of CD8+ T cell-dependent pre-erythrocytic stage malaria vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,330,175 | February 4, 2021 | January 31, 2026 | KAPPE, STEFAN HI | reporter.nih.gov |
| Bioconductor: An Open-Source, Open-Development Computing Resource for Genomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,327,693 | September 28, 2006 | February 28, 2027 | IRIZARRY, RAFAEL ANGEL | reporter.nih.gov |
| Synergistic role of signaling and epigenetics in leukemic transformation | NIH | National Cancer Institute | 2021 to 2025 | $6,322,598 | January 17, 2017 | July 31, 2030 | LEVINE, ROSS L | reporter.nih.gov |
| NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $6,321,134 | September 23, 2025 | September 22, 2026 | GRETCH, DAVID RICHARD | reporter.nih.gov |
| DUAL AFFINITY RE-TARGETING (DART) MOLECULES FOR HIV-1 SUPPRESSION | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $6,287,950 | September 15, 2015 | July 14, 2023 | NORDSTROM, JEFFREY | reporter.nih.gov |
| Early Origins of Chronic Lung Disease: From Birth to Age 45 Years | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,285,181 | June 1, 2016 | June 30, 2030 | MARTINEZ, FERNANDO D | reporter.nih.gov |
| Neuropixels Opto: Integrated Silicon Probes for Cell-Type-Specific Electrophysiology | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $6,281,935 | August 18, 2023 | July 31, 2027 | SVOBODA, KAREL | reporter.nih.gov |
| Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies | NIH | National Cancer Institute | 2022 to 2025 | $6,280,793 | September 14, 2022 | July 31, 2027 | CHAN, TIMOTHY AN-THY | reporter.nih.gov |
| Defining the mechanisms of HIV resistance to bNAbs in humans | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $6,279,096 | July 5, 2022 | April 30, 2027 | CASKEY, MARINA | reporter.nih.gov |
| The PreVAIL-kIds Common Protocol | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 | $6,271,251 | January 1, 2021 | November 30, 2025 | ANNAPRAGADA, ANANTH V | reporter.nih.gov |
| Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV | NIH | National Institute on Drug Abuse | 2022 to 2025 | $6,266,450 | June 15, 2022 | March 31, 2027 | CHENG, CHRISTINE | reporter.nih.gov |
| The National Center for In-situ Tomographic Ultramicroscopy (NCITU) Supplement | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $6,241,625 | September 15, 2020 | August 31, 2027 | KIEFT, JEFFREY S | reporter.nih.gov |
| Translating genomic discoveries to improved outcomes for high risk acute leukemia | NIH | National Cancer Institute | 2021 to 2025 | $6,239,168 | January 19, 2017 | August 31, 2030 | MULLIGHAN, CHARLES G | reporter.nih.gov |
| BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA | NIH | National Cancer Institute | 2022 to 2024 | $6,227,249 | June 15, 2022 | May 15, 2025 | CLAPPER, MARGIE L. | reporter.nih.gov |
| ReproNim: A Center for Reproducible Neuroimaging Computation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,211,472 | April 15, 2016 | August 31, 2026 | KENNEDY, DAVID NELSON | reporter.nih.gov |
| Center for Biomedical OCT Research and Translation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $6,137,829 | July 21, 2011 | March 31, 2027 | BOUMA, BRETT E | reporter.nih.gov |
| Engineered AAV Identification, Validation, and Dissemination Pipeline for Brain Cell Type-Specific Manipulation Across Species | NIH | National Institute of Mental Health | 2021 | $6,133,641 | September 20, 2021 | September 19, 2025 | GRADINARU, VIVIANA | reporter.nih.gov |
| S4 TO 108 NCATS GENE THERAPY VECTOR | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $6,133,050 | September 30, 2021 | September 29, 2024 | KOROLEVA, ANNA | reporter.nih.gov |
| Host and microbial basis of human ulcerative colitis and pouchitis: Identification, role, mechanisms, and resource development of host susceptibility and pathobiont factors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $6,122,586 | September 1, 2019 | May 31, 2025 | CHANG, EUGENE B | reporter.nih.gov |
| Imaging Genetics of Brain Structure and Cognitive Aging in Murine Models of Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2025 | $6,121,279 | February 1, 2021 | January 31, 2027 | WILLIAMS, ROBERT W. | reporter.nih.gov |
| BPN PROJECT BPN-36938 | NIH | National Institute on Drug Abuse | 2021 to 2025 | $6,119,136 | September 17, 2024 | September 16, 2030 | MEITZ, SUSAN | reporter.nih.gov |
| Spinal circuits for mechanical itch and light touch | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,110,688 | May 1, 2019 | April 30, 2027 | GOULDING, MARTYN D | reporter.nih.gov |
| Elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes | NIH | National Institute on Aging | 2022 to 2025 | $6,109,739 | September 15, 2022 | August 31, 2027 | SHEN, YIN | reporter.nih.gov |
| A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,096,179 | September 5, 2023 | June 30, 2028 | SHAPIRO, ROGER L | reporter.nih.gov |
| Single-cell transcriptomic and epigenomic analysis of brain cell vulnerabilities to tauopathies in early AD impacted brain regions | NIH | National Institute on Aging | 2023 to 2025 | $6,093,858 | June 1, 2023 | February 29, 2028 | XU, XIANGMIN | reporter.nih.gov |
| Design and testing of immunogens to elicit 10E8-like broadly neutralizing antibodies against HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $6,090,710 | July 8, 2019 | August 31, 2029 | SCHIFFNER, TORBEN | reporter.nih.gov |
| Center for Biomolecular NMR Data Processing and Analysis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $6,049,058 | September 1, 2015 | May 31, 2025 | HOCH, JEFFREY C | reporter.nih.gov |
| Psychoactive Drug Screening (PDSP) | NIH | National Institute on Drug Abuse | 2021 to 2022 | $6,044,644 | August 30, 2018 | August 29, 2023 | ROTH, BRYAN | reporter.nih.gov |
| TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $6,022,974 | September 30, 2019 | April 30, 2026 | CARSON, DENNIS | reporter.nih.gov |
| A universal pipeline for functional characterization of the human microbiota at a massive scale | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $6,002,443 | April 1, 2020 | March 31, 2026 | BUIE, CULLEN RICHARD | reporter.nih.gov |
| La Spada Outstanding Investigator Award | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $6,002,158 | May 15, 2021 | April 30, 2029 | LA SPADA, ALBERT R | reporter.nih.gov |
| Defining causal roles of genomic variants on gene regulatory networks with spatiotemporally-resolved single-cell multiomics | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,001,599 | September 1, 2021 | May 31, 2026 | WU, HAO | reporter.nih.gov |
| FII Track-2 FEC: Facilitating Ubiquitous Technology Utilizing Resilient Eco-friendly Sensors | NSF | Office of Integrative Activities | 2022 | $6,000,000 | August 1, 2022 | July 31, 2027 | Teresa A Murray | nsf.gov |
| AI Institute for Molecular Discovery, Synthetic Strategy, and Manufacturing: Molecule Maker Lab Institute (MMLI) | NSF | Chemistry Section | 2025 | $6,000,000 | September 1, 2025 | August 31, 2030 | Huimin Zhao | nsf.gov |
| STC: Center for Genome Intelligence Engineering (GENIE) | NSF | Office of Integrative Activities | 2026 | $5,999,989 | September 1, 2026 | August 31, 2031 | Vadim Backman | nsf.gov |
| RII Track-2 FEC: Membrane Purification Platform for Continuous Biomanufacturing of Viral Vectors and Virus-like Particles in Arkansas and Beyond | NSF | Office of Integrative Activities | 2022 | $5,999,758 | August 1, 2022 | July 31, 2027 | Xianghong Qian | nsf.gov |
| RII Track-2 FEC: BioWRAP (Bioplastics With Regenerative Agricultural Properties): Spray-on bioplastics with growth synchronous decomposition and water, nutrient, and agrochemical m | NSF | Office of Integrative Activities | 2022 | $5,999,428 | March 1, 2022 | February 28, 2027 | Vaishali Sharda | nsf.gov |
| E-RISE: EMBEDDEd-NH: Endeavor for Multi-omics-Based Exploration, Data-Driven modeling, and Education in NH | NSF | Office of Integrative Activities | 2026 | $5,999,362 | July 15, 2026 | June 30, 2030 | David B Needle | nsf.gov |
| RII Track-2 FEC: Advancing Manufacturing and Biotechnology through an On-Demand Sensor Platform: Investments in the Development of Engineering Principles and the Future Workforce | NSF | Office of Integrative Activities | 2022 | $5,997,238 | March 1, 2022 | February 28, 2027 | Jeffrey M Halpern | nsf.gov |
| Large scale genome sequencing and integrative analyses to define genomic predictors of recurrent pregnancy loss | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $5,993,004 | April 15, 2021 | October 31, 2026 | JIANG, YONG-HUI | reporter.nih.gov |
| E-RISE: Center for Grassland Ecosystem Forecasting | NSF | Office of Integrative Activities | 2026 | $5,972,396 | September 1, 2026 | August 31, 2030 | Xiangming Xiao | nsf.gov |
| Assessing how ocular surface nerves, immune cells, and epithelial cells communicate to encourage neuro-immune homeostasis | NIH | National Eye Institute | 2022 to 2025 | $5,960,366 | September 30, 2022 | August 31, 2027 | ST LEGER, ANTHONY J | reporter.nih.gov |
| VCID CWOW: Identifying Novel Targets to Treat Cerebral Amyloid Angiopathy | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $5,949,022 | September 18, 2024 | August 31, 2027 | HOWELL, GARETH R | reporter.nih.gov |
| Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $5,933,702 | April 8, 2021 | March 31, 2027 | SIM, B. KIM LEE | reporter.nih.gov |
| Dissecting the role of sex-linked genes and APOE e4 risk in AD | NIH | National Institute on Aging | 2021 to 2025 | $5,928,484 | September 30, 2021 | July 31, 2027 | YOUNG, JESSICA ELAINE | reporter.nih.gov |
| Next-generation spatial -omics: High-throughput, single-molecule proteomic imaging with subcellular resolution | NIH | National Institute of Mental Health | 2023 to 2024 | $5,926,670 | September 18, 2023 | July 31, 2028 | ROUKES, MICHAEL L | reporter.nih.gov |
| IGF::OT::IGF TASK ORDER #001 PERFORMANCE AREA 1 MANAGEMENT AND OPERATIONS SUPPORT | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,922,338 | September 13, 2016 | September 12, 2025 | GREEN, CAROL E | reporter.nih.gov |
| The cBioPortal for Cancer Genomics | NIH | National Cancer Institute | 2022 to 2025 | $5,919,979 | September 5, 2022 | August 31, 2027 | SCHULTZ, NIKOLAUS | reporter.nih.gov |
| DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,907,864 | September 30, 2023 | September 29, 2028 | BURKHART, DAVID | reporter.nih.gov |
| Integrating large scale genomics and functional studies to accelerate FSGS/NS discovery | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $5,901,662 | August 15, 2020 | May 31, 2026 | POLLAK, MARTIN R. | reporter.nih.gov |
| Squirrel Monkey Breeding and Research Resource | NIH | Office of the Director, National Institutes of Health | 2021 to 2025 | $5,901,087 | April 1, 1997 | July 31, 2025 | HOPKINS, WILLIAM D | reporter.nih.gov |
| Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2022 to 2025 | $5,896,816 | August 15, 2022 | May 31, 2027 | KANTHASAMY, ANUMANTHA GOUNDER | reporter.nih.gov |
| Single cell analysis of the kinome | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $5,894,000 | September 15, 2022 | August 31, 2027 | CAI, LONG | reporter.nih.gov |
| Genetic & Social Determinants of Health: Center for Admixture Science and Technology | NIH | National Human Genome Research Institute | 2023 to 2025 | $5,893,601 | July 1, 2023 | June 30, 2027 | OHNO-MACHADO, LUCILA | reporter.nih.gov |
| E-RISE: Nebraska Center for 3D Innovation (NE3D) | NSF | Office of Integrative Activities | 2026 | $5,886,075 | August 15, 2026 | July 31, 2030 | Jorge M Zuniga | nsf.gov |
| Phase IA/IB Study of AAVrh.10hFXN Therapy to Treat the Cardiomyopathy of Friedreich's Ataxia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $5,884,638 | August 1, 2020 | August 31, 2025 | CRYSTAL, RONALD G | reporter.nih.gov |
| High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials | NIH | National Cancer Institute | 2023 to 2025 | $5,867,691 | September 30, 2017 | June 30, 2028 | GNJATIC, SACHA | reporter.nih.gov |
| Sonogenetic Remote Control of Cellular Function | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $5,862,500 | September 30, 2021 | July 31, 2027 | SHAPIRO, MIKHAIL | reporter.nih.gov |
| Novel Biologic Therapies for GVHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,851,412 | February 1, 2010 | June 30, 2026 | KEAN, LESLIE S | reporter.nih.gov |
| NSF Center for Genetically Encoded Materials | NSF | Chemistry Section | 2025 | $5,850,000 | September 1, 2025 | August 31, 2030 | Alanna Schepartz | nsf.gov |
| EHR-based Genomic Discovery and Implementation [Funded Extension] | NIH | National Human Genome Research Institute | 2021 to 2025 | $5,842,673 | August 15, 2011 | April 30, 2026 | SHARP, RICHARD R. | reporter.nih.gov |
| Discovery of adjuvants via novel modulation of innate immune pathways for vaccines against influenza | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,841,904 | September 30, 2019 | April 30, 2026 | ESSER-KAHN, AARON | reporter.nih.gov |
| Mendelian inheritance of artificial chromosomes | NIH | National Human Genome Research Institute | 2021 to 2025 | $5,835,586 | September 10, 2021 | June 30, 2027 | BLACK, BEN E. | reporter.nih.gov |
| Drivers of individual variation in influenza vaccine response and protection from infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,827,282 | July 14, 2022 | June 30, 2027 | COBEY, SARAH | reporter.nih.gov |
| A Proteomic Comparison of Sporadic Early-Onset, Late-Onset, and Autosomal Dominant Alzheimer's Disease | NIH | National Institute on Aging | 2024 to 2025 | $5,825,826 | September 30, 2024 | July 31, 2029 | JOHNSON, ERIK C.B. | reporter.nih.gov |
| E-CORE RII: New Hampshire Long-term Investment to Fuel Transformative Research | NSF | Office of Integrative Activities | 2024 | $5,815,253 | May 15, 2024 | October 31, 2028 | Mark Milutinovich | nsf.gov |
| Identifying Microbial, Epithelial and Immune Cell Interactions that Mediate Mucosal Homeostasis and Determine IBD Phenotypes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $5,810,225 | September 19, 2013 | June 30, 2025 | SARTOR, RYAN B | reporter.nih.gov |
| Annotating Cancer Biology through Non-Invasive Molecular Imaging | NIH | National Cancer Institute | 2021 to 2025 | $5,790,675 | September 4, 2019 | August 31, 2026 | LEWIS, JASON S. | reporter.nih.gov |
| The Role of B cells in the Origin and Progression of Multiple Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,776,308 | May 1, 2019 | April 30, 2027 | HAUSER, STEPHEN L | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Fred Hutchinson Cancer Center | Seattle, WA | 134 | $781 million | 0 | $0 |
| Stanford University | Stanford, CA | 543 | $734 million | 13 | $9.5 million |
| Duke University | Durham, NC | 341 | $722.3 million | 10 | $10.8 million |
| University of Pennsylvania | Philadelphia, PA | 451 | $629 million | 15 | $31.9 million |
| University of California, San Francisco | San Francisco, CA | 475 | $637.5 million | 5 | $3.1 million |
| Johns Hopkins University | Baltimore, MD | 431 | $579.8 million | 12 | $7.9 million |
| Washington University | Saint Louis, MO | 391 | $579.8 million | 6 | $1.9 million |
| Emory University | Atlanta, GA | 318 | $567.5 million | 14 | $7.8 million |
| Massachusetts General Hospital | Boston, MA | 374 | $553.4 million | 1 | $298,662 |
| University of California, San Diego | La Jolla, CA | 360 | $524.2 million | 15 | $10.4 million |
| Yale University | New Haven, CT | 366 | $519 million | 7 | $11.2 million |
| University of Washington | Seattle, WA | 303 | $493.5 million | 14 | $12.6 million |
| Icahn School of Medicine at Mount Sinai | New York, NY | 264 | $494.8 million | 1 | $204,412 |
| Columbia University Health Sciences | New York, NY | 312 | $448.7 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 246 | $446 million | 1 | $184,151 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 302 | $426.4 million | 19 | $9.7 million |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 350 | $406.9 million | 25 | $14.2 million |
| PPD Development LP | Wilmington, NC | 1 | $417.9 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 136 | $402 million | 2 | $1 million |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 318 | $396.2 million | 7 | $3.5 million |
| University of California Los Angeles | Los Angeles, CA | 262 | $340.7 million | 16 | $16.6 million |
| Sloan-Kettering Inst Can Research | New York, NY | 178 | $353 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 247 | $349.3 million | 0 | $0 |
| Broad Institute, Inc. | Cambridge, MA | 96 | $330.4 million | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 81 | $323.5 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 218 | $281.3 million | 21 | $22.8 million |
| Northwestern University at Chicago | Chicago, IL | 192 | $242.6 million | 11 | $39.6 million |
| University of Minnesota | Minneapolis, MN | 228 | $258 million | 16 | $7.9 million |
| Boston Children's Hospital | Boston, MA | 170 | $261.8 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 138 | $260.9 million | 1 | $491,748 |
| University of California-Irvine | Irvine, CA | 171 | $234.4 million | 14 | $14.2 million |
| Dana-Farber Cancer Inst | Boston, MA | 141 | $246.8 million | 1 | $157,741 |
| University of Colorado Denver | Aurora, CO | 201 | $240.1 million | 7 | $4.8 million |
| Weill Medical Coll of Cornell Univ | New York, NY | 153 | $242.4 million | 1 | $1.7 million |
| University of Maryland Baltimore | Baltimore, MD | 166 | $242.9 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 203 | $235.8 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 179 | $234.5 million | 0 | $0 |
| University of Florida | Gainesville, FL | 206 | $215.2 million | 26 | $16.7 million |
| University of Chicago | Chicago, IL | 146 | $198.3 million | 10 | $32.3 million |
| Oregon Health & Science University | Portland, OR | 170 | $229.8 million | 2 | $625,095 |
| New York University School of Medicine | New York, NY | 148 | $222.8 million | 0 | $0 |
| University of California at Davis | Davis, CA | 191 | $202 million | 18 | $20 million |
| Ohio State University | Columbus, OH | 181 | $191 million | 15 | $20.8 million |
| University of Alabama at Birmingham | Birmingham, AL | 171 | $205.3 million | 2 | $1.7 million |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 151 | $205.6 million | 1 | $1.3 million |
| University of Southern California | Los Angeles, CA | 136 | $203.1 million | 6 | $2.7 million |
| University of Utah | Salt Lake City, UT | 167 | $198.9 million | 11 | $5.6 million |
| Florida State University | Tallahassee, FL | 23 | $19.2 million | 12 | $182.5 million |
| Medical College of Wisconsin | Milwaukee, WI | 73 | $188.5 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 116 | $168.5 million | 6 | $9.4 million |
| University of Virginia | Charlottesville, VA | 145 | $174.5 million | 2 | $1.5 million |
| University of Miami School of Medicine | Coral Gables, FL | 103 | $175.3 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 114 | $173.3 million | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 117 | $156.2 million | 18 | $15.3 million |
| University of Illinois at Urbana-Champaign | Urbana, IL | 93 | $118.9 million | 13 | $48.9 million |
| Albert Einstein College of Medicine | Bronx, NY | 115 | $162.5 million | 0 | $0 |
| Jackson Laboratory | Bar Harbor, ME | 78 | $157.3 million | 1 | $465,000 |
| Massachusetts Institute of Technology | Cambridge, MA | 136 | $145.7 million | 5 | $4.6 million |
| Mayo Clinic Rochester | Rochester, MN | 140 | $150 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 138 | $146.1 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 110 | $145.8 million | 0 | $0 |
| Cornell University | Ithaca, NY | 99 | $104.1 million | 11 | $40.6 million |
| ST. Jude Children's Research Hospital | Memphis, TN | 76 | $142.4 million | 0 | $0 |
| University of Georgia Research Foundation Inc | Athens, GA | 62 | $113.3 million | 23 | $28.3 million |
| Beth Israel Deaconess Medical Center | Boston, MA | 71 | $136 million | 0 | $0 |
| Rockefeller University | New York, NY | 58 | $122.1 million | 2 | $12.4 million |
| Beckman Research Institute/city of Hope | Duarte, CA | 73 | $126.6 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 78 | $121.6 million | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 60 | $113 million | 11 | $8.5 million |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 108 | $120.1 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 134 | $119.6 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 104 | $116.8 million | 2 | $512,869 |
| Boston University Medical Campus | Boston, MA | 86 | $116.7 million | 0 | $0 |
| California Institute of Technology | Pasadena, CA | 57 | $110.3 million | 7 | $4.2 million |
| University of Nebraska Medical Center | Omaha, NE | 77 | $112 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 111 | $103.1 million | 6 | $4.3 million |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 79 | $104.9 million | 0 | $0 |
| University of Rochester | Rochester, NY | 89 | $99.9 million | 3 | $685,739 |
| Pennsylvania State Univ University Park | University Park, PA | 72 | $76.6 million | 23 | $23.5 million |
| Seattle Children's Hospital | Seattle, WA | 71 | $99.4 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 71 | $75.4 million | 13 | $23.1 million |
| University of Missouri-Columbia | Columbia, MO | 71 | $85.9 million | 17 | $10.9 million |
| University of Arizona | Tucson, AZ | 82 | $88.1 million | 9 | $5.3 million |
| Purdue University | West Lafayette, IN | 76 | $82.9 million | 21 | $10.3 million |
| Vanderbilt University | Nashville, TN | 111 | $88.6 million | 6 | $3.8 million |
| University of Texas at Austin | Austin, TX | 71 | $62.7 million | 25 | $27.1 million |
| University of California-Santa Cruz | Santa Cruz, CA | 32 | $85.1 million | 4 | $1.9 million |
| Virginia Commonwealth University | Richmond, VA | 94 | $85.6 million | 2 | $873,550 |
| Georgia Tech Research Corporation | Atlanta, GA | 79 | $81.3 million | 10 | $5.1 million |
| Cedars-Sinai Medical Center | Los Angeles, CA | 66 | $86.2 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 64 | $71.9 million | 13 | $13.3 million |
| Temple Univ of the Commonwealth | Philadelphia, PA | 48 | $80.1 million | 3 | $4.9 million |
| University of Texas HLTH Science Center | San Antonio, TX | 81 | $84.9 million | 0 | $0 |
| University of California-Santa Barbara | Santa Barbara, CA | 25 | $24 million | 18 | $59.5 million |
| SUNY at Buffalo | Amherst, NY | 75 | $80.1 million | 4 | $2.7 million |
| University of Maryland, College Park | College Park, MD | 64 | $71.1 million | 13 | $9.1 million |
| Thomas Jefferson University | Philadelphia, PA | 65 | $78.9 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 47 | $74.5 million | 5 | $3.4 million |
| Harvard University | Cambridge, MA | 66 | $68.3 million | 8 | $9.5 million |
| Northwestern University | Chicago, IL | 69 | $77.2 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 918 | $840,520,636 |
| 2025 | 10,185 | $6,430,700,790 | 352 | $314,603,437 |
| 2024 | 10,814 | $6,260,208,218 | 281 | $284,098,940 |
| 2023 | 10,886 | $6,377,743,192 | 190 | $171,756,460 |
| 2022 | 10,755 | $6,349,164,807 | 174 | $99,237,236 |
| 2021 | 10,398 | $6,547,491,766 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.